Researcher Profile and Settings

Researcher

• Name

  ARAKI Takuya

Affiliation

• Clinical Pharmacology and Thearapeutics, Associate Professor

Profile and Settings

• Name

  Araki, Takuya

Affiliation

• Gunma University, Associate Professor

Affiliation

• Affiliation

  Graduate School of Medicine, Clinical Pharmacology and Thearapeutics

• Job title

  Associate Professor

Research Experience

• 2009, 2013, Assistant Professor
• Department of Clinical Pharmacology, Gunma University Graduate School of Medicine
• 2009, 2013, Gunma University, Graduate School of Medicine

Research Activities

Research Areas

• Life sciences, Clinical pharmacy

Research Interests

• Individualized pharmacotherapy

Published Papers

• Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment. Cancer Chemotherapy and Pharmacology, Miki Takenaka Sato, Takuya Araki, Hideaki Yashima, Jun Morita, Masayuki Ohbayashi, Noriko Kohyama, Yoshio Ogawa, Takashi Fukagai, Yuya Ishikawa, Koujirou Yamamoto, Mari Kogo, 2024, Cancer Chemotherapy and Pharmacology, Scientific journal
• 真菌性角膜炎に対する院内製剤1.0％ボリコナゾール点眼液の有効性および安全性の評価, 長嶺歩, 本間真里奈, 石井明日香, 八島秀明, 髙橋雄太, 髙橋恵美利, 荒木拓也, 山本康次郎, 大林恭子, 2024, Scientific journal
• Administration of decapsulated dabigatran via nasal tube: A case report, Akiko Kaneta, Hideaki Yashima, Takuya Araki, Mari Taira, Msahiko Kurabayashi, Koujirou Yamamoto, 2024, American Journal of Health-System Pharmacy, Scientific journal
• Therapeutic drug monitoring of docetaxel: a case report of administration of docetaxel for breast cancer patient receiving rifampicin and clarithromycin treatment for non-tuberculous mycobacteriosis, Hideaki Yashima, Takuya Araki, Yuya Ishikawa, Sohei Oshima, Daisuke Nagano, Kyoko Obayashi, Jun Horiguchi, Koujirou Yamamoto, 2024, Molecular and Clinical Oncology, Scientific journal
• Patient resuscitated after cardiopulmonary arrest exhibits abnormally increased phenytoin metabolic rate due to unknown factors: a case report, Ayumu Nagamine, Takuya Araki, Hideaki Yashima, Kiyohiro Oshima, Kyoko Obayashi, Koujirou Yamamoto, Aug. 2024, Journal of Pharmaceutical Health Care and Sciences, 10, 1, 53, Scientific journal
• Effect of genetic factors on the interindividual variability of warfarin dosage requirements in Japanese patients after adjusting for renal function, Hiromi Nishiba, Ayumu Nagamine, Hideaki Yashima, Yuta Takahashi, Yuya Higuchi, Naoto Sekizaki, Hironori Nakamura, Takuya Araki, Noriaki Takama, Norimichi Koitabashi, Tadashi Nakajima, Yoshiaki Kaneko, Yoshiaki Ohyama, Tomoyuki Yokoyama, Kunihiko Imai, Masahiko Kurabayashi, Koujirou Yamamoto, Kyoko Obayashi, Aug. 2024, Pharmazie, 79, 173, 177, Scientific journal

  DOI
• Plasma prolactin axis shift from placental to pituitary origin in late prepartum mice, Taku James Sairenji, Shinnosuke Masuda, Yuya Higuchi, Mitsue Miyazaki, Hiroyuki Yajima, Oh Kwan Ee, Yuki Fujiwara, Takuya Araki, Noriaki Shimokawa, Noriyuki Koibuchi, May 2024, Endocrine Journal, 71, 7, 661, 674, Scientific journal
• Risk of Falls with Benzodiazepine Receptor Agonists in Combination with Novel hypnotics, Yuya Higuchi, Yuya Ishikawa, Takuya Araki, Yukina Ohshima, Hideaki Yashima, Koujirou Yamamoto, Apr. 2024, Indonesian Journal of Pharmaceutics, 5, 2, 377, 384, Scientific journal
• Increased c‑SRC expression is involved in acquired resistance to lenvatinib in hepatocellular carcinoma., Takahashi Masamitsu;Araki Takuya;Yashima Hideaki;Nagamine Ayumu;Nagano Daisuke;Yamamoto Koujirou, Oct. 2023, Oncology letters, 26, 6, 529, Scientific journal

  DOI
• Blood Concentration of Cabazitaxel in a Patient Whose General Condition Worsened with Concomitant Use of Clarithromycin., Katsumi Shigeaki;Araki Takuya;Yashima Hideaki;Miyazawa Yoshiyuki;Suzuki Kazuhiro;Yamamoto Koujirou, Jul. 2023, Case reports in oncology, 16, 1, 503, 509, Scientific journal

  DOI
• Risk of exposure of patients' family members to lenalidomide at home., Takahashi Yuta;Nagamine Ayumu;Kaneta Akiko;Yashima Hideaki;Obayashi Kyoko;Araki Takuya;Yamamoto Koujirou, Jun. 2023, European journal of hospital pharmacy, Scientific journal

  DOI
• Hospitalized patients on orexin receptor antagonists have a lower risk of falls, Yukina Ohshima, Takuya Araki, Hideaki Yashima, Noriyuki Nakayama, Koujirou Yamamoto, Mar. 2023, Indonesian Journal of Pharmaceutics, 4, 2, 232, 241, Scientific journal
• Target concentration achievement for efficacy and safety of osteosarcoma patients treated with high dose methotrexate based on individual pharmacokinetics: A retrospective study, Ayumu Nagamine, Takuya Araki, Hideaki Yashima, Akane Kamimura, Takumi Shiraishi, Takashi Yanagawa, Kyoko Obayashi, Koujirou Yamamoto, Feb. 2023, Oncology letters, 25, 2, 70, Scientific journal
• management of poisoning induced by beta adrenergic blockers and calcium channel blockers with refractory shock: a case report), Mizuki Mori, Yusuke Sawada, Yuto Aramaki, Jun Nakajima, Hideaki Yashima, Takuya Araki, Kiyohiro Oshima, Feb. 2023, 34, 2, 55, 60, Scientific journal
• Prevention of postoperative cognitive dysfunction by minocycline in elderly patients following total knee arthroplasty: A randomized double-blind placebo controlled clinical trial, Tomonori Takazawa, Tatsuo Horiuchi, Masaki Orihara, Kazuhiro Nagumo, Akihiro Tomioka, Yuki Ideno, Kunihiko Hayashi, Hideaki Yashima, Takuya Araki, Kazuhisa Hatayama, Masanori Terauchi, Yoshio Ikeda, Shigeru Saito, Dec. 2022, Anesthesiology, 138, 2, 172, 183, Scientific journal
• Comparison of the clinical utility of aprepitant/granisetron and palonosetron combined with dexamethasone as an antiemetic therapy in patients treated with paclitaxel and carboplatin combination therapy for gynecological cancers: a retrospective cohort study, Kyoko Obayashi, Ayumu Nagamine, Hideaki Yashima, Chino Uchiyama, Sohei Ohshima, Emiri Takahashi, Yuta Takahashi, Takuya Araki, Koujirou Yamamoto, May 2022, Pharmazie, 77, 5, 157, 161, Scientific journal
• Development of a quantitative method for sunitinib N-oxide, Yuya Ishikawa, Takuya Araki, Miki Takenaka Sato, Hideaki Yashima, Daisuke Nagano, Koujirou Yamamoto, Feb. 2022, Indonesian Journal of Pharmaceutics, 3, 2, 88, 98, Scientific journal
• Effect of nicotine- and tar-removed cigarette smoke extract on cancer metastasis, Yuta Takahashi, Takuya Araki, Hideaki Yashima, Ayumu Nagamine, Daisuke Nagano, Kyoko Obayashi, Koujirou Yamamoto, Nov. 2021, Indonesian Journal of Pharmaceutics, 3, 2, 45, 59, Scientific journal
• 乳糖水和物中に含まれる牛乳アレルギー誘引タンパク質の測定系の検討, 八島 秀明;荒木 拓也;羽鳥 真由;山本 康次郎, Sep. 2021, 34, 1, 66, 70, Scientific journal
• A recent update of anticoagulant therapy on severe COVID-19 patients, Taofik Rusdiana, Norisca Aliza Putriana, Patihul Husni, Mohammad Rizki Akbar, Takuya Araki, Anas Subarnas, Sep. 2021, Journal of Research in Pharmacy, 25, 6, 807, 814, Scientific journal
• The influence of Javanese turmeric (Curcuma xanthorrhiza) on the pharmacokinetics of warfarin in rats with single and multiple-dose studies., Rusdiana Taofik;Mardhiani Yanni D;Putriana Norisca A;Gozali Dolih;Nagano Daisuke;Araki Takuya;Yamamoto Koujirou, Jun. 2021, Pharmaceutical biology, 59, 1, 639, 646, Scientific journal

  DOI
• 少量の散剤を分包した際の分包内重量の評価, ;;;, Dec. 2020, 34, 1, 118
• Simple and Rapid Method for Determination of Abemaciclib in Human Serum Using Supported Liquid Extraction Pretreatment and LC-MS/MS Analysis, Naoto Sekizaki, Hideaki Yashima, Takuya Araki, Koujirou Yamamoto, Dec. 2020, Indonesian Journal of Pharmaceutics, 2, 3, 97, 103, Scientific journal
• Correction to: FLEND (nelarabine, fludarabine, and etoposide) for relapsed T-cell acute lymphoblastic leukemia in children: a report from Japan Children's Cancer Group., Kumamoto Tadashi;Goto Hiroaki;Ogawa Chitose;Hori Toshinori;Deguchi Takao;Araki Takuya;Saito Akiko M;Manabe Atsushi;Horibe Keizo;Toyoda Hidemi, Aug. 2020, International journal of hematology, 113, 2, Scientific journal

  DOI
• The reductive activity of human liver microsomes for vitamin K epoxides, Masashi Kawano, Takuya Araki, Hideaki Yashima, Tomonori Nakamura, Koujirou Yamamoto, Feb. 2020, Indonesian Journal of Pharmaceutics, 2, 1, 7, 13, Scientific journal
• 術前薬剤師面談の実施に向けた取り組みと課題点, ;;;;;, Oct. 2019, 39, 6, S226
• 群馬大学医学部附属病院集中治療室における注射薬配合変化回避に向けた取り組み, ;;;;;;;;;, Feb. 2019, 26, Suppl., [P45
• L-Lactate dehydrogenase B may be a predictive marker for sensitivity to anti-EGFR monoclonal antibodies in colorectal cancer cell lines., Nagamine Ayumu;Araki Takuya;Nagano Daisuke;Miyazaki Mitsue;Yamamoto Koujirou, Feb. 2019, Oncology letters, 17, 5

  DOI
• The impact of sunitinib N-oxide as a photodegradation product of sunitinib, Miki Takenaka, Yuta Takahashi, Hideaki Yashima, Takuya Araki, Koujirou Yamamoto, 2019, Indonesian Journal of Pharmaceutics, 1, 1, 19, 25, Scientific journal
• Exploration of proteins involved in acquisition of resistance to cetuximab, Hironori Nakamura, Ayumu Nagamine, Hideaki Yashima, Takuya Araki, Koujirou Yamamoto, 2019, Indonesian Journal of Pharmaceutics, 1, 1, 11, 18, Scientific journal
• ホスフェニトイン投与後に血中フェニトイン濃度が異常低値を生じた症例, ;;;;;;;;;;, May 2018, 35, 2, 157
• 患者のQOL向上と薬剤師の関わり(PART I.)　院内製剤　院内製剤点眼液の品質管理の取り組み, ;;;;;, May 2018, 54, 5, 1271
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients., Nagano Daisuke;Araki Takuya;Yanagisawa Kunio;Ogawa Yoshiyuki;Gohda Fumito;Uchiumi Hideki;Handa Hiroshi;Nakamura Tomonori;Yamamoto Koujirou, May 2018, European journal of clinical pharmacology, 74, 8

  DOI
• 検査値に関連した疑義照会事例の解析, 矢内優, 八島秀明, 阿部正樹, 荒木拓也, 山本康次郎, 2018, 48, 3, 41, 43, Scientific journal
• "Effect of a Dietary Supplement Containing Raspberry Ketone on CYP3A Activity in Healthy Women", Tohru Aomori, JingWei Qi, Yuko Okada, Katsunori Nakamura, Haruhiko Hiraoka, Takuya Araki, Tomonori Nakamura, Ryuya Horiuchi, Koujirou Yamamoto, 2018, Pharmaceutica Analytica Acta, 9, 6, 1000587, Scientific journal
• A retrospective study to assess the risk of falls due to prescribed drugs in inpatients, Yashima, Hideaki;Araki, Takuya;Shibamiya, Taku;Komatsu, Yasuhiro;Yamamoto, Koujirou, 2018, PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 27, 483, 484
• 群馬大学医学部附属病院における糖尿病チーム医療での薬剤師の取り組み , 石渕一恵, 山田英二郎, 井川八重子, 斎賀桐子, 長谷川信, 飯塚 誠, 八島秀明, 阿部正樹, 荒木拓也, 山本康次郎, 2017, 43, 3, 10-13.
• 高齢者医療で求められるフィジカルアセスメントとは, 竹中美貴, 大林恭子, 伊部洋子, 須賀達夫, 飯塚 誠, 八島秀明, 阿部正樹, 荒木拓也, 山本康次郎, 2017, 43, 3, 17-19
• 重度精神運動発達遅滞を持つ腎移植患者に対し、服薬コンプライアンスの向上に関与した1例, 真下貴子, 飯塚 誠, 関根芳岳, 八島秀明, 阿部正樹, 荒木拓也,　鈴木和浩, 山本康次郎, 2017, 43, 3, 13-16
• セツキシマブ単剤療法施行時に発現した肝障害に対応し、治療を継続できた１例 , 樋口裕哉, 飯塚 誠, 八島秀明, 阿部正樹, 荒木拓也, 山本康次郎, 2017, 43, 3, 20-22
• Endogenous analgesic effect of pregabalin: A double-blind and randomized controlled trial, Sugimine, S.; Saito, S.; Araki, T.; Yamamoto, K.; Obata, H., 2017, EUROPEAN JOURNAL OF PAIN

  DOI
• Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3, Ito, Ayano; Okada, Yuko; Hashita, Tadahiro; Aomori, Tohru; Hiromura, Keiju; Nojima, Yoshihisa; Nakamura, Tomonori; Araki, Takuya; Yamamoto, Koujirou, 2017, BIOCHEMICAL GENETICS

  DOI
• 腎疾患, 荒木 拓也, Nov. 2017, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 27, 0, 623, 625

  DOI
• ダルナビル・コビシスタット配合錠に変更後のダルナビル血中濃度の検討, ;;;;;;;;, Nov. 2017, 19, 4, 428
• ラルテグラビル投与時の錠剤粉砕等による血中濃度への影響の検討, ;;;;;;;;, Nov. 2017, 19, 4, 496
• Significant decreases in blood propofol concentrations during adrenalectomy for phaeochromocytoma, Watanabe, Tatsunori; Hiraoka, Haruhiko; Araki, Takuya; Nagano, Daisuke; Aomori, Tohru; Nakamura, Tomonori; Yamamoto, Koujirou; Baba, Hiroshi, Oct. 2017, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

  DOI
• Significant decreases in blood propofol concentrations during adrenalectomy for phaeochromocytoma., Watanabe Tatsunori;Hiraoka Haruhiko;Araki Takuya;Nagano Daisuke;Aomori Tohru;Nakamura Tomonori;Yamamoto Koujirou;Baba Hiroshi, Jul. 2017, British journal of clinical pharmacology, 83, 10

  DOI
• Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3., Ito Ayano;Okada Yuko;Hashita Tadahiro;Aomori Tohru;Hiromura Keiju;Nojima Yoshihisa;Nakamura Tomonori;Araki Takuya;Yamamoto Koujirou, Mar. 2017, Biochemical genetics, 55, 3

  DOI
• 食道癌サルベージ手術症例における手術前の筋肉量と合併症発現リスクおよび長期予後の関係に関する調査, ;;;;;;;;;;;;;;, Jan. 2017, 32, Suppl., 395
• Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3, Ito, Ayano;Okada, Yuko;Hashita, Tadahiro;Aomori, Tohru;Hiromura, Keiju;Nojima, Yoshihisa;Nakamura, Tomonori;Araki, Takuya;Yamamoto, Koujirou, 2017, BIOCHEMICAL GENETICS, 55, 3, 268, 277

  DOI
• Significant decreases in blood propofol concentrations during adrenalectomy for phaeochromocytoma, Watanabe, Tatsunori;Hiraoka, Haruhiko;Araki, Takuya;Nagano, Daisuke;Aomori, Tohru;Nakamura, Tomonori;Yamamoto, Koujirou;Baba, Hiroshi, 2017, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 83, 10, 2205, 2213

  DOI
• Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation, Tomita, Hideharu; Araki, Takuya; Kadokami, Toshiaki; Yamada, Satoshi; Nakamura, Ryo; Imamura, Yoshihiro; Fukuyama, Takaya; Nagano, Daisuke; Hashimoto, Tomoya; Uematsu, Akiko; Hosokawa, Kazuya; Yamamoto, Koujirou; Ueda, Shin-ichiro; Ando, Shin-ichi, 2016, THROMBOSIS RESEARCH

  DOI
• Prognostic potential of the MDM2 309T > G polymorphism in stage I lung adenocarcinoma, Enokida, Yasuaki; Shimizu, Kimihiro; Atsumi, Jun; Kakegawa, Seiichi; Takase, Yoshiaki; Kaira, Kyoichi; Yashima, Hideaki; Araki, Takuya; Nakazawa, Seshiru; Ohtaki, Yoichi; Nagashima, Toshiteru; Alexander, Lezhava; Usui, Kengo; Ishikawa, Toshihisa; Hayashizaki, Yoshihide; Takeyoshi, Izumi, 2016, CANCER MEDICINE

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Yanagisawa, Kunio; Nagano, Daisuke; Ogawa, Yoshiyuki; Uchiumi, Hideki; Shigehara, Tetsuya; Saruki, Kazuhisa; Handa, Hiroshi; Araki, Takuya; Yamamoto, Koujirou; Nojima, Yoshihisa, 2016, AIDS

  DOI
• 58　糖尿病 2, 荒木 拓也, Sep. 2016, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 26, 0, 19-6-O58, 19-6-O58

  DOI
• Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation., Tomita Hideharu;Araki Takuya;Kadokami Toshiaki;Yamada Satoshi;Nakamura Ryo;Imamura Yoshihiro;Fukuyama Takaya;Nagano Daisuke;Hashimoto Tomoya;Uematsu Akiko;Hosokawa Kazuya;Yamamoto Koujirou;Ueda Shin-Ichiro;Ando Shin-Ichi; , Jun. 2016, Thrombosis research, 145

  DOI
• Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma., Enokida Yasuaki;Shimizu Kimihiro;Atsumi Jun;Kakegawa Seiichi;Takase Yoshiaki;Kaira Kyoichi;Yashima Hideaki;Araki Takuya;Nakazawa Seshiru;Ohtaki Yoichi;Nagashima Toshiteru;Alexander Lezhava;Usui Kengo;Ishikawa Toshihisa;Hayashizaki Yoshihide;Takeyoshi Izumi, May 2016, Cancer medicine, 5, 8

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Yanagisawa, Kunio;Nagano, Daisuke;Ogawa, Yoshiyuki;Uchiumi, Hideki;Shigehara, Tetsuya;Saruki, Kazuhisa;Handa, Hiroshi;Araki, Takuya;Yamamoto, Koujirou;Nojima, Yoshihisa, 2016, AIDS, 30, 6, 970, 972

  DOI
• Prognostic potential of the MDM2 309T > G polymorphism in stage I lung adenocarcinoma, Enokida, Yasuaki;Shimizu, Kimihiro;Atsumi, Jun;Kakegawa, Seiichi;Takase, Yoshiaki;Kaira, Kyoichi;Yashima, Hideaki;Araki, Takuya;Nakazawa, Seshiru;Ohtaki, Yoichi;Nagashima, Toshiteru;Alexander, Lezhava;Usui, Kengo;Ishikawa, Toshihisa;Hayashizaki, Yoshihide;Takeyoshi, Izumi, 2016, CANCER MEDICINE, 5, 8, 1791, 1801

  DOI
• Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation, Tomita, Hideharu;Araki, Takuya;Kadokami, Toshiaki;Yamada, Satoshi;Nakamura, Ryo;Imamura, Yoshihiro;Fukuyama, Takaya;Nagano, Daisuke;Hashimoto, Tomoya;Uematsu, Akiko;Hosokawa, Kazuya;Yamamoto, Koujirou;Ueda, Shin-ichiro;Ando, Shin-ichi;ATTACK-DB Res Grp, 2016, THROMBOSIS RESEARCH, 145, 100, 106

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study., Yanagisawa Kunio;Nagano Daisuke;Ogawa Yoshiyuki;Uchiumi Hideki;Shigehara Tetsuya;Saruki Kazuhisa;Handa Hiroshi;Araki Takuya;Yamamoto Koujirou;Nojima Yoshihisa, 2016, AIDS (London, England), 30, 6, 970, 972, Scientific journal

  DOI
• 臨床に求められる研究能力（基礎と臨床の融合のために）, 荒木 拓也, 2015, 75, 341-343
• Development of a predictive method for sensitivity to anti-EGFR Mabs using proteome analysis, Nagamine, Ayumu;Nagano, Daisuke;Araki, Takuya;Yamamoto, Koujirou, 2015, PHARMACOTHERAPY, 35, 11, E200, E201
• Research Ability Required for Scientist Pharmacist —Fusion of Basic Research and Clinical Expertise—, Araki Takuya, 2015, Journal of Pharmaceutical Science and Technology, Japan, 75, 6, 341, 343

  DOI
• Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats, Ogawa, Junji; Yokota, Azusa; Araki, Takuya; Aomori, Tohru; Nakamura, Tomonori; Yamamoto, Koujirou; Koshiishi, Ichiro, 2014, BIOPHARMACEUTICS & DRUG DISPOSITION

  DOI
• Effect of a dietary supplement containing raspberry ketone on cytochrome P450 3A activity, Masayuki Sekizuka, Jing Wei Qi, Tohru Aomori, Yuko Okada, Katsunori Nakamura, Takuya Araki, Ryuya Horiuchi, Shin Ohta, Tomonori Nakamura, Koujirou Yamamoto, 2014, Pharmaceutica Analytica Acta

  DOI
• Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients, Hideaki Yashima, Kimihiro Shimizu, Takuya Araki, Tohru Aomori, Yoichi Ohtaki, Toshiteru Nagashima, Yasuaki Enokida, Jun Atsumi, Tomonori Nakamura, Izumi Takeyoshi, Koujirou Yamamoto, 2014, Molecular and Clinical Oncology

  DOI
• 小児急性リンパ性白血病患者に対するメトトレキサート大量投与時の血中メトトレキサート濃度推移と投与回数の関係, 中村浩規,荒木拓也,塚本純子,飯塚恵子,山本康次郎, Dec. 2014, 27, 59-62
• Determination of Intracellular Darunavir by Liquid Chromatography Coupled with Fluorescence Detection, Nagano, Daisuke; Araki, Takuya; Nakamura, Tomonori; Yamamoto, Koujirou, Oct. 2014, JOURNAL OF CHROMATOGRAPHIC SCIENCE

  DOI
• Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats., Ogawa Junji;Yokota Azusa;Araki Takuya;Aomori Tohru;Nakamura Tomonori;Yamamoto Koujirou;Koshiishi Ichiro, Aug. 2014, Biopharmaceutics & drug disposition, 35, 6

  DOI
• Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients., Yashima Hideaki;Shimizu Kimihiro;Araki Takuya;Aomori Tohru;Ohtaki Yoichi;Nagashima Toshiteru;Enokida Yasuaki;Atsumi Jun;Nakamura Tomonori;Takeyoshi Izumi;Yamamoto Koujirou, Jun. 2014, Molecular and clinical oncology, 2, 5

  DOI
• Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats, Ogawa, Junji;Yokota, Azusa;Araki, Takuya;Aomori, Tohru;Nakamura, Tomonori;Yamamoto, Koujirou;Koshiishi, Ichiro, 2014, BIOPHARMACEUTICS & DRUG DISPOSITION, 35, 6, 362, 371

  DOI
• Determination of Intracellular Darunavir by Liquid Chromatography Coupled with Fluorescence Detection, Nagano, Daisuke;Araki, Takuya;Nakamura, Tomonori;Yamamoto, Koujirou, 2014, JOURNAL OF CHROMATOGRAPHIC SCIENCE, 52, 9, 1021, 1025

  DOI
• リジェクトされない臨床薬学研究のキホン！（３）カバーレターの書き方とエディター・レフリーのコメントに対応するポイント, 荒木拓也,山本康次郎, 2013, 64, 8, 2257-2262
• Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients, Kyoko Obayashi, Takuya Araki, Katsunori Nakamura, Masahiko Kurabayashi, Yoshihisa Nojima, Katsuyuki Hara, Tomonori Nakamura, Koujirou Yamamoto, 2013, Drugs in R&D

  DOI
• Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population, Rusdiana, T.; Araki, T.; Nakamura, T.; Subarnas, A.; Yamamoto, K., 2013, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

  DOI
• SENSITIVE AND SIMPLE DETERMINATION OF VITAMIN K1 IN HUMAN PLASMA BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH A FLUORESCENCE DETECTOR, Ohno, Izumi; Araki, Takuya; Kawano, Masashi; Nakamura, Tomonori; Yamamoto, Koujirou, 2013, JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES

  DOI
• Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents, Fujita, Y.; Araki, T.; Okada, Y.; Aomori, T.; Shimizu, R.; Tomizawa, T.; Hiromura, K.; Nojima, Y.; Nakamura, T.; Yamamoto, K., 2013, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

  DOI
• Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection., Nagano Daisuke;Araki Takuya;Nakamura Tomonori;Yamamoto Koujirou, Nov. 2013, Journal of chromatographic science, 52, 9

  DOI
• 土-P2-106 RF-IDを利用した内服処方薬の調剤進捗管理システムの導入と評価(一般演題 ポスター発表,調剤・処方鑑査,再興、再考、創ろう最高の医療の未来), ;;;;;;;, Aug. 2013, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 23, 0, 269

  DOI
• SENSITIVE AND SIMPLE DETERMINATION OF VITAMIN K1 IN HUMAN PLASMA BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH A FLUORESCENCE DETECTOR, Ohno, Izumi;Araki, Takuya;Kawano, Masashi;Nakamura, Tomonori;Yamamoto, Koujirou, 2013, JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 36, 8, 1068, 1077

  DOI
• Risk of falling and hypnotic drugs: retrospective study of inpatients., Obayashi Kyoko;Araki Takuya;Nakamura Katsunori;Kurabayashi Masahiko;Nojima Yoshihisa;Hara Katsuyuki;Nakamura Tomonori;Yamamoto Koujirou, 2013, Drugs in R&D, 13, 2, 159, 164, Scientific journal

  DOI
• Review of the treatment of non-small cell lung cancer with gefitinib., Araki Takuya;Yashima Hideaki;Shimizu Kimihiro;Aomori Tohru;Hashita Tadahiro;Kaira Kyoichi;Nakamura Tomonori;Yamamoto Koujirou, Dec. 2012, Clinical Medicine Insights. Oncology, 6

  DOI
• Review of the treatment of non-small-cell lung cancer with gefitinib, Takuya Araki, Hideaki Yashima, Kimihiro Shimizu, Tohru Aomori, Tadahiro Hashita, Kyoichi Kaira, Tomonori Nakamura, Koujirou Yamamoto, Oct. 2012, Clinical Medicine Insights: Oncology
• PNA-clamp SmartAmp2を用いたEGFRおよびKRAS遺伝子変異解析法の構築と臨床応用(Postdoctoral Award受賞講演,岐路に立つ医療～千年紀の目覚め～よみがえれ!ニッポン!薬の改革は我らが手で!), 荒木 拓也, Oct. 2012, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 22, 0, 166

  DOI
• S2D-2-4 私はこのようにして論文を書いている(シンポジウム S2D-2 医療薬学研究の成果を論文に投稿しよう!,岐路に立つ医療～千年紀の目覚め～よみがえれ!ニッポン!薬の改革は我らが手で!), 荒木 拓也, Oct. 2012, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 22, 0, 231

  DOI
• Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents, Fujita Yukiyoshi, Araki Takuya, Okada Yuko, Aomori Tohru, Shimizu Rumi, Tomizawa Takeshi, Hiromura Keiju, Nojima Yoshihisa, Nakamura Tomonori, Yamamoto Koujirou, Aug. 2012, Journal of Clinical Pharmacy and Therapeutics
• Design and Synthesis of Indomethacin Analogues that inhibit P-glycoprotein and/or Multi-drug Resistant Protein without Cox Inhibitory Activity, Arisawa, Mitsuhiro; Kasaya, Yayoi; Obata, Tohru; Sasaki, Takuma; Nakamura, Tomonori; Araki, Takuya; Yamamoto, Koujirou; Sasaki, Akito; Yamano, Akihito; Ito, Mika; Abe, Hiroshi; Ito, Yoshihiro; Shuto, Satoshi, Aug. 2012, Journal of Medicinal Chemistry
• Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population, T Rusdiana, T Araki, T Nakamura, A Subarnas, K Yamamoto, Jul. 2012, European Journal of Clinical Pharmacology
• Effect of genetic polymorphisms (TPMT, ITPA, IMPDH1, XO and MRP4) on the efficacy of low-dose azathioprine therapy in Japanese patients with systemic lupus erythematosus, Ayumu Nagamine, Miki Takenaka, Tohru Aomori, Yuko Okada, Keiju Hiromura, Yoshihisa Nojima, Takuya Araki, Tomonori Nakamura and Koujirou Yamamoto, Jun. 2012, American Journal of Health-System Pharmacy
• Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath, Tohru Aomori, Hironori Makino, Masayuki Sekizuka, Tadahiro Hashita, Takuya Araki, Keiko Iizuka, Tomonori Nakamura and Koujirou Yamamoto, May 2012, Drugs in R&D
• Sensitive and simple determination of vitamin K1 in human plasma by ultra-performance liquid chromatography coupled with a fluorescence detector, Izumi Ohno, Takuya Araki, Masashi Kawano, Tomonori Nakamura, Koujirou Yamamoto, Apr. 2012, Journal of liquid chromatography & related technologies
• Clinical efficacy of two forms of intravenous iron-saccharated ferric oxide and cideferron-for iron deficiency anemia, Takuya Araki, Mari Takaai, Ai Miyazaki, Sohei Ohshima, Taku Shibamiya, Tomonori Nakamura, Koujirou Yamamoto, Apr. 2012, Pharmazie
• Ruthenium-catalyzed cycloisomerization of 1,3-dienes, for example, an N-dienyl-2-vinylaniline derivative, leading to a 3-Exomethylene-2-vinylindole derivative and its application to the synthesis of (±)-cinchonaminone, Takao Ogawa, Tomonori Nakamura, Takuya Araki, Koujiro Yamamoto, Satoshi Shuto, Mitsuhiro Arisawa , 2012, European Journal of Organic Chemistry
• Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography, Achmad, Arifudin;Hanaoka, Hirofumi;Yoshioka, Hiroki;Yamamoto, Shinji;Tominaga, Hideyuki;Araki, Takuya;Ohshima, Yasuhiro;Oriuchi, Noboru;Endo, Keigo, 2012, CANCER SCIENCE, 103, 3, 600, +

  DOI
• Ruthenium-Catalyzed Cycloisomerization and Its Application to the Synthesis of (+/-)-Cinchonaminone, Ogawa, Takao;Nakamura, Tomonori;Araki, Takuya;Yamamoto, Koujirou;Shuto, Satoshi;Arisawa, Mitsuhiro, 2012, EUROPEAN JOURNAL OF ORGANIC CHEMISTRY, 2012, 16, 3084, 3087

  DOI
• Design and Synthesis of Indomethacin Analogues That Inhibit P-Glycoprotein and/or Multidrug Resistant Protein without Cox Inhibitory Activity, Arisawa, Mitsuhiro;Kasaya, Yayoi;Obata, Tohru;Sasaki, Takuma;Nakamura, Tomonori;Araki, Takuya;Yamamoto, Koujirou;Sasaki, Akito;Yamano, Akihito;Ito, Mika;Abe, Hiroshi;Ito, Yoshihiro;Shuto, Satoshi, 2012, JOURNAL OF MEDICINAL CHEMISTRY, 55, 18, 8152, 8163

  DOI
• Correlation between the concentration of darunavir in PBMCs and plasma in the HIV-infected patients., Nagano, Daisuke;Araki, Takuya;Yanagisawa, Kunio;Ogawa, Masayuki;Hayashi, Toshimasa;Gouda, Fumito;Mawatari, Momoko;Uchiumi, Hideki;Nojima, Yoshihisa;Nakamura, Tomonori;Yamamoto, Koujirou, 2012, PHARMACOTHERAPY, 32, 10, E291, E291
• Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus, Nagamine, Ayumu;Takenaka, Miki;Aomori, Tohru;Okada, Yuko;Hiromura, Keiju;Nojima, Yoshihisa;Araki, Takuya;Nakamura, Tomonori;Yamamoto, Koujirou, 2012, AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 69, 23, 2072, 2078

  DOI
• Effect of ethanol in Paclitaxel injections on the ethanol concentration in exhaled breath., Aomori Tohru;Makino Hironori;Sekizuka Masayuki;Hashita Tadahiro;Araki Takuya;Iizuka Keiko;Nakamura Tomonori;Yamamoto Koujirou, 2012, Drugs in R&D, 12, 3, 165, 170

  DOI
• Effect of genetic polymorphisms on effectiveness of low-dose azathioprine in Japanese patients with systemic lupus erythematosus., Nagamine Ayumu;Takenaka Miki;Aomori Tohru;Okada Yuko;Hiromura Keiju;Nojima Yoshihisa;Araki Takuya;Nakamura Tomonori;Yamamoto Koujirou, 2012, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 69, 23, 2072, 2078, Scientific journal

  DOI
• Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography., Achmad Arifudin;Hanaoka Hirofumi;Yoshioka Hiroki;Yamamoto Shinji;Tominaga Hideyuki;Araki Takuya;Ohshima Yasuhiro;Oriuchi Noboru;Endo Keigo, Dec. 2011, Cancer science, 103, 3

  DOI
• Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using (64) Cu-labeled cetuximab positron emission tomography, Achmad A, Hanaoka H, Yoshioka H, Yamamoto S, Tominaga H, Araki T, Ohshima Y, Oriuchi N, Endo K, Nov. 2011, Cancer Science
• CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects, K Nakamura, Kyoko Obayashi , Takuya Araki, Tohru Aomori, Yukiyoshi Fujita, Yuko Okada, Masahiko Kurabayashi, Akira Hasegawa, Shigeru Ohmori, Tomonori Nakamura and Koujirou Yamamoto, Oct. 2011, Journal of Clinical Pharmacy and Therapeutics
• Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinoma., Sugano Masayuki;Shimizu Kimihiro;Nakano Tetsuhiro;Kakegawa Seiichi;Miyamae Yohei;Kaira Kyoichi;Araki Takuya;Kamiyoshihara Mitsuhiro;Kawashima Osamu;Takeyoshi Izumi, Aug. 2011, Oncology reports, 26, 5

  DOI
• Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinoma., Araki Takuya;Shimizu Kimihiro;Nakamura Tomonori;Baba Masaru;Kawai Yuki;Nakamura Katsunori;Mitani Yasumasa;Obayashi Kyoko;Aomori Tohru;Fujita Yukiyoshi;Miyamae Yohei;Kakegawa Seiichi;Kaira Kyoichi;Lezhava Alexander;Hayashizaki Yoshihide;Takeyoshi Izumi;Yamamoto Koujirou, Jul. 2011, Oncology reports, 26, 5

  DOI
• Clinicopathological features of lung adenocarcinoma with KRAS mutations., Kakegawa Seiichi;Shimizu Kimihiro;Sugano Masayuki;Miyamae Yohei;Kaira Kyoichi;Araki Takuya;Nakano Tetsuhiro;Kamiyoshihara Mitsuhiro;Kawashima Osamu;Takeyoshi Izumi, Mar. 2011, Cancer, 117, 18

  DOI
• Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma., Miyamae Yohei;Shimizu Kimihiro;Hirato Junko;Araki Takuya;Tanaka Kazumi;Ogawa Hiroomi;Kakegawa Seiichi;Sugano Masayuki;Nakano Tetsuhiro;Mitani Yasumasa;Kaira Kyoichi;Takeyoshi Izumi, Feb. 2011, Oncology reports, 25, 4

  DOI
• Significance of Epidermal growth factor receptor gene mutational analysis for differential diagnosis in squamous cell lung carcinoma., Miyamae Y, Shimizu K, Hirato J, Araki T, Tanaka K, Ogawa H, Kakegawa S, Sugano M, Nakano T, Kaira K, Takeyoshi I, 2011, oncology reports
• Clinicopathological Features of Lung Adenocarcinoma with KRAS Mutations., Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I, 2011, Cancer
• Correlation between Computed Tomography Findings and Epidermal Growth Factor Receptor and KRAS Gene Mutations in Patients with Peripheral Pulmonary Adenocarcinoma, Sugano M, Shimizu K, Kakegawa S, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Takeyoshi I, 2011, Oncology Reports
• Clinical screening assay of EGFR mutations by PNA-clamp Smart Amplification Proces Version 2 in lung adenocarcinoma, Araki T, Shimizu K, Nakamura T, Baba M, Kawai Y, Nakamura K, Mitani Y, Obayashi K, Aomori T, Fujita Y, Miyamae Y, Kakegawa S, Kaira K, Lezhava A, Hayashizaki Y, Takeyoshi, Yamamoto K, 2011, Oncology Reports
• 液体調整器具を用いた抗がん薬注射剤調製手技の未熟達者における評価, 藤田行代志、関塚雅之、中村智徳、本徳理恵、阿部正樹、中村克徳、荒木拓也、飯塚惠子、山本康次郎, 2011, 37, 2, 91-96
• A case of fatal drug intoxication showing a high-density duodenal content by postmortem computed tomography, Sano, Rie;Takahashi, Keiko;Kominato, Yoshihiko;Araki, Takuya;Yamamoto, Koujiro;Takei, Hiroyuki;Otake, Hidenori;Awata, Sachiko;Akuzawa, Hisashi;Tago, Yoko;Aoki, Hideo, 2011, LEGAL MEDICINE, 13, 1, 39, 40

  DOI
• Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma, Miyamae, Yohei;Shimizu, Kimihiro;Hirato, Junko;Araki, Takuya;Tanaka, Kazumi;Ogawa, Hiroomi;Kakegawa, Seiichi;Sugano, Masayuki;Nakano, Tetsuhiro;Mitani, Yasumasa;Kaira, Kyoichi;Takeyoshi, Izumi, 2011, ONCOLOGY REPORTS, 25, 4, 921, 928

  DOI
• Clinicopathological Features of Lung Adenocarcinoma With KRAS Mutations, Kakegawa, Seiichi;Shimizu, Kimihiro;Sugano, Masayuki;Miyamae, Yohei;Kaira, Kyoichi;Araki, Takuya;Nakano, Tetsuhiro;Kamiyoshihara, Mitsuhiro;Kawashima, Osamu;Takeyoshi, Izumi, 2011, CANCER, 117, 18, 4257, 4266

  DOI
• Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinoma, Sugano, Masayuki;Shimizu, Kimihiro;Nakano, Tetsuhiro;Kakegawa, Seiichi;Miyamae, Yohei;Kaira, Kyoichi;Araki, Takuya;Kamiyoshihara, Mitsuhiro;Kawashima, Osamu;Takeyoshi, Izumi, 2011, ONCOLOGY REPORTS, 26, 5, 1205, 1211

  DOI
• Clinical screening assay for EGFR exon 19 mutations using PNA-clamp smart amplification process version 2 in lung adenocarcinoma, Araki, Takuya;Shimizu, Kimihiro;Nakamura, Tomonori;Baba, Masaru;Kawai, Yuki;Nakamura, Katsunori;Mitani, Yasumasa;Obayashi, Kyoko;Aomori, Tohru;Fujita, Yukiyoshi;Miyamae, Yohei;Kakegawa, Seiichi;Kaira, Kyoichi;Lezhava, Alexander;Hayashizaki, Yoshihide;Takeyoshi, Izumi;Yamamoto, Koujirou, 2011, ONCOLOGY REPORTS, 26, 5, 1213, 1219

  DOI
• DETERMINATION OF LANDIOLOL IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH FLUORESCENCE DETECTION, Aomori, Tohru;Matsumoto, Naoki;Nakamura, Katsunori;Fujita, Yukiyoshi;Sekizuka, Masayuki;Araki, Takuya;Nakamura, Tomonori;Yamamoto, Koujirou, 2011, JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 34, 19, 2411, 2419

  DOI
• Evaluation of Drug Transfer Device for Use in Preparation of Anticancer Drugs by Unskilled Persons, Fujita Yukiyoshi;Sekizuka Masayuki;Nakamura Tomonori;Hontoku Rie;Abe Tadashige;Nakamura Katsunori;Araki Takuya;Iizuka Keiko;Yamamoto Koujirou, 2011, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 37, 2, 91, 96

  DOI
• Influence of CYP2C9 and VKORC1 polymorphisms on time to determine the warfarin maintenance dose., Aomori T, Obayashi K, Fujita Y, Araki T, Nakamura K, Nakamura T, Kurabayashi M, Yamamoto K, Dec. 2010, Die Pharmazie
• A case of fatal drug intoxication showing a high-density duodenal content by postmortem computed tomography. , Sano R, Takahashi K, Kominato Y, Araki T, Yamamoto K, Takei H, Otake H, Awata S, Akuzawa H, Tago Y, Aoki H. , Dec. 2010, Legal Medicine
• A case of fatal drug intoxication showing a high-density duodenal content by postmortem computed tomography., Sano Rie;Takahashi Keiko;Kominato Yoshihiko;Araki Takuya;Yamamoto Koujiro;Takei Hiroyuki;Otake Hidenori;Awata Sachiko;Akuzawa Hisashi;Tago Yoko;Aoki Hideo, Dec. 2010, Legal medicine (Tokyo, Japan), 13, 1

  DOI
• P1-259 CYP2C19活性低下およびCYP3A5欠損患者においてイトラコナゾールからボリコナゾールへの変更によりタクロリムス血中濃度が5倍上昇した症例(一般演題 ポスター発表,薬物治療と遺伝多型,臨床から学び臨床へと還元する医療薬学), ;;;;;, Oct. 2010, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 20, 0, 330

  DOI
• P2-079 透析液中のセファゾリンの安定性についての検討(一般演題 ポスター発表,品質管理,臨床から学び臨床へと還元する医療薬学), ;;;;, Oct. 2010, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 20, 0, 403

  DOI
• OP-237-1 新規遺伝子増幅技術SmartAmp法を用いた肺癌におけるKRAS遺伝子変異の解析(肺基礎-2,一般口演,第110回日本外科学会定期学術集会), ;;;;;;;;Alexander Lezhava;, Mar. 2010, Journal of Japan Surgical Society, 111, 2, 653
• Mutation detection of Epidermal Growth Factor Receptor and KRAS genes using the Smart Amplification Process Version 2 from formalin-fixed, paraffin-embedded lung cancer tissure., Miyamae Y, Shimizu K, Mitani Y, Araki T, Kawai Y, Baba M, Kakegawa S, Sugano M, Kaira K, Lezhava A, Hayashizaki Y, Yamamoto K, Takeyoshi I, Feb. 2010, Journal of Molecular Diagnosis
• Usefulness of peptide nucleic acid (PNA)-clamp Smart Amplification Process Version 2 (SmartAmp2) for clinical diagnosis of KRAS codon12 mutations in lung adenocarcinoma: comparison of PPNA-clamp SmartAmp2 and Polymerase Chain Reaction-related methods., Araki T, Shimizu K, Nakamura K, Nakamura T, Mitani Y, Obayashi K, Fujita Y, Kakegawa S, Miyamae Y, Kaira K, Ishidao T, Lezhava A, Hayashizaki Y, Takeyosi I, Yamamoto K, Jan. 2010, Journal of Molecular Diagnosis
• Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue., Miyamae Yohei;Shimizu Kimihiro;Mitani Yasumasa;Araki Takuya;Kawai Yuki;Baba Masaru;Kakegawa Seiichi;Sugano Masayuki;Kaira Kyoichi;Lezhava Alexander;Hayashizaki Yoshihide;Yamamoto Koujirou;Takeyoshi Izumi, Jan. 2010, The Journal of molecular diagnostics : JMD, 12, 2

  DOI
• Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon 12 Mutations in Lung Adenocarcinoma Comparison of PNA-Clamp SmartAmp2 and PCR-Related Methods, Araki, Takuya;Shimizu, Kimihiro;Nakamura, Katsunori;Nakamura, Tomonori;Mitani, Yasumasa;Obayashi, Kyoko;Fujita, Yukiyoshi;Kakegawa, Seiichi;Miyamae, Yohei;Kaira, Kyoichi;Ishidao, Takefumi;Lezhava, Alexander;Hayashizaki, Yoshihide;Takeyoshi, Izumi;Yamamoto, Koujirou, 2010, JOURNAL OF MOLECULAR DIAGNOSTICS, 12, 1, 118, 124

  DOI
• Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded Lung Cancer Tissue, Miyamae, Yohei;Shimizu, Kimihiro;Mitani, Yasumasa;Araki, Takuya;Kawai, Yuki;Baba, Masaru;Kakegawa, Seiichi;Sugano, Masayuki;Kaira, Kyoichi;Lezhava, Alexander;Hayashizaki, Yoshihide;Yamamoto, Koujirou;Takeyoshi, Izumi, 2010, JOURNAL OF MOLECULAR DIAGNOSTICS, 12, 2, 257, 264

  DOI
• THE IMPACT OF VKORC1 AND CYP2C9 GENETIC POLYMORPHISM ON WARFARIN RESPONSE IN INDONESIAN PATIENTS, Rusdiana Taofik;Koyama Hiroshi;Subarnas Anas;Yamamoto Koujirou;Araki Takuya;Putriana Norisca;Handayani Sari;Lestari Keri;Diantini Ajeng;Mutakin Mutakin;Fujita Yukiyoshi;Nakamura Tomonori, 2010, Abstracts of Annual meeting of Japanese Society for the Study of Xenobiotics, 25, 0, 61, 61

  DOI
• Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods., Araki Takuya;Shimizu Kimihiro;Nakamura Katsunori;Nakamura Tomonori;Mitani Yasumasa;Obayashi Kyoko;Fujita Yukiyoshi;Kakegawa Seiichi;Miyamae Yohei;Kaira Kyoichi;Ishidao Takefumi;Lezhava Alexander;Hayashizaki Yoshihide;Takeyoshi Izumi;Yamamoto Koujirou, Dec. 2009, The Journal of molecular diagnostics : JMD, 12, 1

  DOI
• SF-022-3 SMAP法による肺癌の遺伝子解析 : 様々な臨床検体を用いた検討(肺・気管・気管支(悪性疾患2),サージカルフォーラム,第109回日本外科学会定期学術集会), ;;;;;;;;Alexander Lezhava;, Feb. 2009, Journal of Japan Surgical Society, 110, 2
• HP-233-4 乳癌を合併した肺腺癌症例におけるEGFR遺伝子変異解析(肺(遺伝子診断・腫瘍マーカー),ハイブリッドポスター,第109回日本外科学会定期学術集会), ;;;;;;;;;;, Feb. 2009, Journal of Japan Surgical Society, 110, 2
• HP-233-5 リンパ節転移をきたした肺腺癌手術症例におけるEGFR遺伝子変異と臨床病理学的因子との関連(肺(遺伝子診断・腫瘍マーカー),ハイブリッドポスター,第109回日本外科学会定期学術集会), ;;;;;;;LEZHAVA Alexander;, Feb. 2009, Journal of Japan Surgical Society, 110, 2
• HP-230-7 非小細胞肺癌におけるMDM 2遺伝子多型と喫煙,EGFR・KRAS遺伝子変異との関連についての検討(肺(発癌・悪性度・転移),ハイブリッドポスター,第109回日本外科学会定期学術集会), ;;;;;;;, Feb. 2009, Journal of Japan Surgical Society, 110, 2, 774, 774
• Effective application of PNA-clamp in Smart Amplification Process Version 2 for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma, Shimizu, Kimihiro;Mitani, Yasumasa;Araki, Takuya;Miyamae, Yohei;Kakegawa, Seiichi;Nakamura, Katsunori;Obayashi, Kyoko;Lezhava, Alexander;Hayashizaki, Yoshihide;Yamamoto, Koujirou;Takeyoshi, Izumi, 2009, JOURNAL OF THORACIC ONCOLOGY, 4, 9, S637, S638
• DETERMINATION OF GENETIC POLYMORPHISM OF CYP2C9 AND VKORC1 AS A CONTRIBUTOR OF WARFARIN DOSE IN INDONESIAN POPULATION, Rusdiana Taofik;Yamamoto Koujirou;Nakamura Katsunori;Araki Takuya;mutakin Mutakin;Lestari Keri;Abdasah Marline;Nakamura Tomonori;Koyama Hiroshi;Subarnas Anas, 2009, Abstracts of Annual meeting of Japanese Society for the Study of Xenobiotics, 24, 0, 312, 312

  DOI
• O-14 肺腺癌におけるMDM2遺伝子多型と喫煙EGFR遺伝子変異との関連についての検討(分子生物学,第49回日本肺癌学会総会号), ;;;;;;;, Oct. 2008, Japanese Journal of Lung Cancer, 48, 5
• P-46 超高感度・高速遺伝子変異検索システムSMAP法を用いた肺癌における迅速遺伝子診断(基礎研究,第49回日本肺癌学会総会号), ;;;;;;;;, Oct. 2008, Japanese Journal of Lung Cancer, 48, 5
• 臨床応用のためのSNP診断技術, 三谷康正, 荒木拓也, 太田郁子, 2008, 33, 5, 791-796
• O09-05 超高感度・高速遺伝子変異検索システムSMAP法の呼吸器外科領域への臨床応用(先端技術,第25回日本呼吸器外科学会総会), ;;;;;;LEZHAVA Alexander;;, 2008, The Journal of the Japanese Association for Chest Surgery, 22, 3

  DOI
• 20-P3-492 個別化医療のためのSMAP法を用いたEGFR、K-ras遺伝子変異検出(薬物動態(遺伝子多型),来るべき時代への道を拓く), ;;Alexander Lezhava;;;;;;;;;;;, 2008, The Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, 18, 0

  DOI
• バイオシミラー導入の実際と課題　群馬大学医学部附属病院におけるBSの導入事例, 荒木 拓也, May 2024, 第18回学術大会要旨集, 47
• Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity., Arisawa Mitsuhiro;Kasaya Yayoi;Obata Tohru;Sasaki Takuma;Nakamura Tomonori;Araki Takuya;Yamamoto Koujirou;Sasaki Akito;Yamano Akihito;Ito Mika;Abe Hiroshi;Ito Yoshihiro;Shuto Satoshi, Sep. 2012, Journal of medicinal chemistry, 55, 18

  DOI
• Plasma prolactin axis shift from placental to pituitary origin in late prepartum mice., Sairenji Taku James;Masuda Shinnosuke;Higuchi Yuya;Miyazaki Mitsue;Yajima Hiroyuki;Kwan Ee Oh;Fujiwara Yuki;Araki Takuya;Shimokawa Noriaki;Koibuchi Noriyuki, May 2024, Endocrine journal, 71, 7

  DOI
• Patient resuscitated after cardiopulmonary arrest exhibits abnormally increased phenytoin metabolic rate due to unknown factors: a case report., Nagamine Ayumu;Araki Takuya;Yashima Hideaki;Oshima Kiyohiro;Obayashi Kyoko;Yamamoto Koujirou, Aug. 2024, Journal of pharmaceutical health care and sciences, 10, 1

  DOI

MISC

• バイオシミラー導入の実際と課題　群馬大学医学部附属病院におけるBSの導入事例, 荒木 拓也, May 2024, 第18回学術大会要旨集, 47
• 【社会基盤としての医療情報の役割】本格化するHL7 FHIRの活用と,普及に向けた課題と展望　汎用型FHIRインターフェース(IPCIコンセプト)を電子カルテに直結した院外調剤薬局との電子処方箋および病名,トレーシングレポート交換機能の実装と運用, 鳥飼 幸太;阿部 正樹;荒木 拓也;野口 怜;齋藤 勇一郎, Jun. 2023, 43, 2, 76
• 急性期病院における入院患者の転倒イベントと睡眠薬服用の関係, 大島 幸菜;荒木 拓也;八島 秀明;中山 典幸;山本 康次郎, May 2023, 6回, 63
• ドラビリンの血中薬物濃度解析を行った透析症例, 樋口 裕哉;柳澤 邦雄;松本 彬;小川 孔幸;半田 寛;中村 聡洋;石崎 芳美;荒木 拓也;山本 康次郎, Nov. 2022, 24, 4, 464
• 本格化するHL7 FHIRの活用と、普及に向けた課題と展望　汎用型FHIRインターフェース(IPCIコンセプト)を電子カルテに直結した院外調剤薬局との電子処方箋および病名、トレーシングレポート交換機能の実装と運用, 鳥飼 幸太;阿部 正樹;荒木 拓也;野口 怜;齋藤 勇一郎, Nov. 2022, 42回, 520
• 鶏卵アレルギーの誘発リスクがあるとされる薬剤中の鶏卵由来タンパク質の分析法の検討, 羽鳥 真由;八島 秀明;荒木 拓也;山本 康次郎, Sep. 2022, 35, 1, 125
• 副作用の重症度評価が可能なトレーシングレポートの運用に関する評価, 田中 悠介;大島 宗平;富田 拓夢;芝宮 拓;八島 秀明;阿部 正樹;荒木 拓也;山本 康次郎, May 2022, 5回, 67
• アベマシクリブ投与中に重度の副作用を発現した2症例におけるアベマシクリブおよび代謝物の解析, 八島 秀明;荒木 拓也;羽鳥 真由;大島 宗平;関崎 直人;阿部 正樹;藤井 孝明;山本 康次郎, May 2022, 39, 2, 147
• 難治性ショックを伴う複数種類の降圧薬中毒に対し集学的治療で救命し得た1例, 森 瑞樹;澤田 悠輔;八島 秀明;荒木 拓也;荒巻 裕斗;福島 一憲;市川 優美;一色 雄太;中島 潤;大嶋 清宏, Oct. 2021, 34, 3, 234
• V-A ECMOを使用したコルヒチン中毒の一剖検例, 澤田 悠輔;村田 将人;神戸 将彦;市川 優美;中島 潤;八島 秀明;荒木 拓也;早川 輝;小湊 慶彦;大嶋 清宏, Sep. 2020, 33, 2, 156
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients, Daisuke Nagano,Takuya Araki,Kunio Yanagisawa,Yoshiyuki Ogawa,Fumito Gohda,Hideki Uchiumi,Hiroshi Handa,Tomonori Nakamura,Koujirou Yamamoto, 2018, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 74, 8, 1055, 1060

  DOI
• Darunavir concentration in PBMCs may be a better indicator of drug exposure in HIV patients, Daisuke Nagano,Takuya Araki,Kunio Yanagisawa,Yoshiyuki Ogawa,Fumito Gohda,Hideki Uchiumi,Hiroshi Handa,Tomonori Nakamura,Koujirou Yamamoto, 2018, 74, 8, 1055, 1060

  DOI
• Significant decreases in blood propofol concentrations during adrenalectomy for phaeochromocytoma, Tatsunori Watanabe,Haruhiko Hiraoka,Takuya Araki,Daisuke Nagano,Tohru Aomori,Tomonori Nakamura,Koujirou Yamamoto,Hiroshi Baba, Oct. 2017, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 83, 10, 2205, 2213

  DOI
• Significant decreases in blood propofol concentrations during adrenalectomy for phaeochromocytoma, Tatsunori Watanabe,Haruhiko Hiraoka,Takuya Araki,Daisuke Nagano,Tohru Aomori,Tomonori Nakamura,Koujirou Yamamoto,Hiroshi Baba, Oct. 2017, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 83, 10, 2205, 2213

  DOI
• Endogenous analgesic effect of pregabalin: A double-blind and randomized controlled trial, S. Sugimine,S. Saito,T. Araki,K. Yamamoto,H. Obata, Jul. 2017, EUROPEAN JOURNAL OF PAIN, 21, 6, 997, 1006

  DOI
• Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3, Ayano Ito,Yuko Okada,Tadahiro Hashita,Tohru Aomori,Keiju Hiromura,Yoshihisa Nojima,Tomonori Nakamura,Takuya Araki,Koujirou Yamamoto, Jun. 2017, BIOCHEMICAL GENETICS, 55, 3, 268, 277

  DOI
• Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3, Ayano Ito,Yuko Okada,Tadahiro Hashita,Tohru Aomori,Keiju Hiromura,Yoshihisa Nojima,Tomonori Nakamura,Takuya Araki,Koujirou Yamamoto, Jun. 2017, BIOCHEMICAL GENETICS, 55, 3, 268, 277

  DOI
• Endogenous analgesic effect of pregabalin: A double-blind and randomized controlled trial, Sugimine\, S,Saito\, S,Araki\, T,Yamamoto\, K,Obata\, H, 2017, EUROPEAN JOURNAL OF PAIN, 21, 6, 997, 1006

  DOI
• 高齢者医療で求められるフィジカルアセスメントとは, 竹中美貴,大林恭子,伊部洋子,須賀達夫,飯塚 誠,八島秀明,阿部正樹,荒木拓也,山本康次郎, 2017, 43, 3, 17, 19
• 群馬大学医学部附属病院における糖尿病チーム医療での薬剤師の取り組み, 石渕一恵,山田英二郎,井川八重子,斎賀桐子,長谷川信,飯塚 誠,八島秀明,阿部正樹,荒木拓也,山本康次郎, 2017, 43, 3, 10-13.
• 重度精神運動発達遅滞を持つ腎移植患者に対し、服薬コンプライアンスの向上に関与した1例, 真下貴子,飯塚 誠,関根芳岳,八島秀明,阿部正樹,荒木拓也,鈴木和浩,山本康次郎, 2017, 43, 3, 13, 16
• セツキシマブ単剤療法施行時に発現した肝障害に対応し、治療を継続できた１例, 樋口裕哉,飯塚 誠,八島秀明,阿部正樹,荒木拓也,山本康次郎, 2017, 43, 3, 20, 22
• Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation, Hideharu Tomita,Takuya Araki,Toshiaki Kadokami,Satoshi Yamada,Ryo Nakamura,Yoshihiro Imamura,Takaya Fukuyama,Daisuke Nagano,Tomoya Hashimoto,Akiko Uematsu,Kazuya Hosokawa,Koujirou Yamamoto,Shin-ichiro Ueda,Shin-ichi Ando, Sep. 2016, THROMBOSIS RESEARCH, 145, 100, 106

  DOI
• Factors influencing trough and 90-minute plasma dabigatran etexilate concentrations among patients with non-valvular atrial fibrillation, Hideharu Tomita,Takuya Araki,Toshiaki Kadokami,Satoshi Yamada,Ryo Nakamura,Yoshihiro Imamura,Takaya Fukuyama,Daisuke Nagano,Tomoya Hashimoto,Akiko Uematsu,Kazuya Hosokawa,Koujirou Yamamoto,Shin-ichiro Ueda,Shin-ichi Ando, Sep. 2016, THROMBOSIS RESEARCH, 145, 100, 106

  DOI
• Prognostic potential of the MDM2 309T > G polymorphism in stage I lung adenocarcinoma, Yasuaki Enokida,Kimihiro Shimizu,Jun Atsumi,Seiichi Kakegawa,Yoshiaki Takase,Kyoichi Kaira,Hideaki Yashima,Takuya Araki,Seshiru Nakazawa,Yoichi Ohtaki,Toshiteru Nagashima,Lezhava Alexander,Kengo Usui,Toshihisa Ishikawa,Yoshihide Hayashizaki,Izumi Takeyoshi, Aug. 2016, CANCER MEDICINE, 5, 8, 1791, 1801

  DOI
• Prognostic potential of the MDM2 309T > G polymorphism in stage I lung adenocarcinoma, Yasuaki Enokida,Kimihiro Shimizu,Jun Atsumi,Seiichi Kakegawa,Yoshiaki Takase,Kyoichi Kaira,Hideaki Yashima,Takuya Araki,Seshiru Nakazawa,Yoichi Ohtaki,Toshiteru Nagashima,Lezhava Alexander,Kengo Usui,Toshihisa Ishikawa,Yoshihide Hayashizaki,Izumi Takeyoshi, Aug. 2016, CANCER MEDICINE, 5, 8, 1791, 1801

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Kunio Yanagisawa,Daisuke Nagano,Yoshiyuki Ogawa,Hideki Uchiumi,Tetsuya Shigehara,Kazuhisa Saruki,Hiroshi Handa,Takuya Araki,Koujirou Yamamoto,Yoshihisa Nojima, Mar. 2016, AIDS, 30, 6, 970, 972, Report scientific journal

  DOI
• Raltegravir is safely used with long-term viral suppression for HIV-infected patients on hemodialysis: a pharmacokinetic study, Kunio Yanagisawa,Daisuke Nagano,Yoshiyuki Ogawa,Hideki Uchiumi,Tetsuya Shigehara,Kazuhisa Saruki,Hiroshi Handa,Takuya Araki,Koujirou Yamamoto,Yoshihisa Nojima, Mar. 2016, AIDS, 30, 6, 970, 972, Report scientific journal

  DOI
• 臨床に求められる研究能力（基礎と臨床の融合のために）, 荒木 拓也, 2015, 75, 341, 343
• Determination of Intracellular Darunavir by Liquid Chromatography Coupled with Fluorescence Detection, Daisuke Nagano,Takuya Araki,Tomonori Nakamura,Koujirou Yamamoto, Oct. 2014, JOURNAL OF CHROMATOGRAPHIC SCIENCE, 52, 9, 1021, 1025

  DOI
• Determination of Intracellular Darunavir by Liquid Chromatography Coupled with Fluorescence Detection, Daisuke Nagano,Takuya Araki,Tomonori Nakamura,Koujirou Yamamoto, Oct. 2014, JOURNAL OF CHROMATOGRAPHIC SCIENCE, 52, 9, 1021, 1025

  DOI
• Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats, Junji Ogawa,Azusa Yokota,Takuya Araki,Tohru Aomori,Tomonori Nakamura,Koujirou Yamamoto,Ichiro Koshiishi, Sep. 2014, BIOPHARMACEUTICS & DRUG DISPOSITION, 35, 6, 362, 371

  DOI
• Quantitative evaluation of biliary elimination of gadoxetate, a magnetic resonance imaging contrast agent, via geometrical isomer-specific transporting system in rats, Junji Ogawa,Azusa Yokota,Takuya Araki,Tohru Aomori,Tomonori Nakamura,Koujirou Yamamoto,Ichiro Koshiishi, Sep. 2014, BIOPHARMACEUTICS & DRUG DISPOSITION, 35, 6, 362, 371

  DOI
• Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients, Hideaki Yashima,Kimihiro Shimizu,Takuya Araki,Tohru Aomori,Yoichi Ohtaki,Toshiteru Nagashima,Yasuaki Enokida,Jun Atsumi,Tomonori Nakamura,Izumi Takeyoshi,Koujirou Yamamoto, 2014, Molecular and Clinical Oncology, 2, 5, 714, 718

  DOI
• Effect of a dietary supplement containing raspberry ketone on cytochrome P450 3A activity, Masayuki Sekizuka,Jing Wei Qi,Tohru Aomori,Yuko Okada,Katsunori Nakamura,Takuya Araki,Ryuya Horiuchi,Shin Ohta,Tomonori Nakamura,Koujirou Yamamoto, 2014, Pharmaceutica Analytica Acta, 5, 6, 302

  DOI
• Assessment of DDR2, BRAF, EGFR and KRAS mutations as therapeutic targets in non-adenocarcinoma lung cancer patients, Hideaki Yashima,Kimihiro Shimizu,Takuya Araki,Tohru Aomori,Yoichi Ohtaki,Toshiteru Nagashima,Yasuaki Enokida,Jun Atsumi,Tomonori Nakamura,Izumi Takeyoshi,Koujirou Yamamoto, 2014, 2, 5, 714, 718

  DOI
• 小児急性リンパ性白血病患者に対するメトトレキサート大量投与時の血中メトトレキサート濃度推移と投与回数の関係, 中村浩規,荒木拓也,塚本純子,飯塚恵子,山本康次郎, 2014, 27, 59, 62
• Effect of a dietary supplement containing raspberry ketone on cytochrome P450 3A activity, Masayuki Sekizuka,Jing Wei Qi,Tohru Aomori,Yuko Okada,Katsunori Nakamura,Takuya Araki,Ryuya Horiuchi,Shin Ohta,Tomonori Nakamura,Koujirou Yamamoto, 2014, 5, 6, 302

  DOI
• Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population, T. Rusdiana,T. Araki,T. Nakamura,A. Subarnas,K. Yamamoto, Mar. 2013, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 69, 3, 395, 405

  DOI
• Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population, T. Rusdiana,T. Araki,T. Nakamura,A. Subarnas,K. Yamamoto, Mar. 2013, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 69, 3, 395, 405

  DOI
• Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population, T. Rusdiana,T. Araki,T. Nakamura,A. Subarnas,K. Yamamoto, Mar. 2013, EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 69, 3, 395, 405

  DOI
• Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents, Y. Fujita,T. Araki,Y. Okada,T. Aomori,R. Shimizu,T. Tomizawa,K. Hiromura,Y. Nojima,T. Nakamura,K. Yamamoto, Feb. 2013, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 38, 1, 74, 76

  DOI
• Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents, Y. Fujita,T. Araki,Y. Okada,T. Aomori,R. Shimizu,T. Tomizawa,K. Hiromura,Y. Nojima,T. Nakamura,K. Yamamoto, Feb. 2013, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 38, 1, 74, 76

  DOI
• Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents, Y. Fujita,T. Araki,Y. Okada,T. Aomori,R. Shimizu,T. Tomizawa,K. Hiromura,Y. Nojima,T. Nakamura,K. Yamamoto, Feb. 2013, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 38, 1, 74, 76

  DOI
• Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents, Y. Fujita,T. Araki,Y. Okada,T. Aomori,R. Shimizu,T. Tomizawa,K. Hiromura,Y. Nojima,T. Nakamura,K. Yamamoto, Feb. 2013, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 38, 1, 74, 76

  DOI
• Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients, Kyoko Obayashi,Takuya Araki,Katsunori Nakamura,Masahiko Kurabayashi,Yoshihisa Nojima,Katsuyuki Hara,Tomonori Nakamura,Koujirou Yamamoto, 2013, Drugs in R&D, 13, 2, 159, 164

  DOI
• SENSITIVE AND SIMPLE DETERMINATION OF VITAMIN K1 IN HUMAN PLASMA BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH A FLUORESCENCE DETECTOR, Ohno\, Izumi,Araki\, Takuya,Kawano\, Masashi,Nakamura\, Tomonori,Yamamoto\, Koujirou, 2013, JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 36, 8, 1068, 1077

  DOI
• Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population, Rusdiana\, T,Araki\, T,Nakamura\, T,Subarnas\, A,Yamamoto\, K, 2013, 69, 3, 395, 405

  DOI
• Risk of Falling and Hypnotic Drugs: Retrospective Study of Inpatients, Kyoko Obayashi,Takuya Araki,Katsunori Nakamura,Masahiko Kurabayashi,Yoshihisa Nojima,Katsuyuki Hara,Tomonori Nakamura,Koujirou Yamamoto, 2013, 13, 2, 159, 164

  DOI
• SENSITIVE AND SIMPLE DETERMINATION OF VITAMIN K1 IN HUMAN PLASMA BY ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY COUPLED WITH A FLUORESCENCE DETECTOR, Ohno\, Izumi,Araki\, Takuya,Kawano\, Masashi,Nakamura\, Tomonori,Yamamoto\, Koujirou, 2013, 36, 8, 1068, 1077

  DOI
• リジェクトされない臨床薬学研究のキホン！（３）カバーレターの書き方とエディター・レフリーのコメントに対応するポイント, 荒木拓也,山本康次郎, 2013, 64, 8, 2257, 2262
• Clinical efficacy of two forms of intravenous iron-saccharated ferric oxide and cideferron-for iron deficiency anemia, T. Araki,M. Takaai,A. Miyazaki,S. Ohshima,T. Shibamiya,T. Nakamura,K. Yamamoto, Dec. 2012, PHARMAZIE, 67, 12, 1030, 1032

  DOI
• Clinical efficacy of two forms of intravenous iron-saccharated ferric oxide and cideferron-for iron deficiency anemia, T. Araki,M. Takaai,A. Miyazaki,S. Ohshima,T. Shibamiya,T. Nakamura,K. Yamamoto, Dec. 2012, PHARMAZIE, 67, 12, 1030, 1032

  DOI
• Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without Cox inhibitory activity, Mitsuhiro Arisawa,Yayoi Kasaya,Tohru Obata,Takuma Sasaki,Tomonori Nakamura,Takuya Araki,Koujirou Yamamoto,Akito Sasaki,Akihito Yamano,Mika Ito,Hiroshi Abe,Yoshihiro Ito,Satoshi Shuto, 27 Sep. 2012, Journal of Medicinal Chemistry, 55, 18, 8152, 8163

  DOI
• Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without Cox inhibitory activity, Mitsuhiro Arisawa,Yayoi Kasaya,Tohru Obata,Takuma Sasaki,Tomonori Nakamura,Takuya Araki,Koujirou Yamamoto,Akito Sasaki,Akihito Yamano,Mika Ito,Hiroshi Abe,Yoshihiro Ito,Satoshi Shuto, 27 Sep. 2012, Journal of Medicinal Chemistry, 55, 18, 8152, 8163

  DOI
• CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects, K. Nakamura,K. Obayashi,T. Araki,T. Aomori,Y. Fujita,Y. Okada,M. Kurabayashi,A. Hasegawa,S. Ohmori,T. Nakamura,K. Yamamoto, Aug. 2012, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 37, 4, 481, 485

  DOI
• CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects, K. Nakamura,K. Obayashi,T. Araki,T. Aomori,Y. Fujita,Y. Okada,M. Kurabayashi,A. Hasegawa,S. Ohmori,T. Nakamura,K. Yamamoto, Aug. 2012, JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 37, 4, 481, 485

  DOI
• Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography, Arifudin Achmad,Hirofumi Hanaoka,Hiroki Yoshioka,Shinji Yamamoto,Hideyuki Tominaga,Takuya Araki,Yasuhiro Ohshima,Noboru Oriuchi,Keigo Endo, Mar. 2012, CANCER SCIENCE, 103, 3, 600, +

  DOI
• Predicting cetuximab accumulation in KRAS wild-type and KRAS mutant colorectal cancer using 64Cu-labeled cetuximab positron emission tomography, Arifudin Achmad,Hirofumi Hanaoka,Hiroki Yoshioka,Shinji Yamamoto,Hideyuki Tominaga,Takuya Araki,Yasuhiro Ohshima,Noboru Oriuchi,Keigo Endo, Mar. 2012, CANCER SCIENCE, 103, 3, 600, +

  DOI
• Ruthenium-catalyzed cycloisomerization of 1,3-dienes, for example, an N-dienyl-2-vinylaniline derivative, leading to a 3-Exomethylene-2-vinylindole derivative and its application to the synthesis of (±)-cinchonaminone, Takao Ogawa,Tomonori Nakamura,Takuya Araki,Koujiro Yamamoto,Satoshi Shuto,Mitsuhiro Arisawa, 2012, European Journal of Organic Chemistry

  DOI
• Sensitive and simple determination of vitamin K1 in human plasma by ultra-performance liquid chromatography coupled with a fluorescence detector, Izumi Ohno,Takuya Araki,Masashi Kawano,Tomonori Nakamura,Koujirou Yamamoto, 2012, Journal of liquid chromatography & related technologies

  DOI
• Review of the treatment of non-small-cell lung cancer with gefitinib, Takuya Araki,Hideaki Yashima,Kimihiro Shimizu,Tohru Aomori,Tadahiro Hashita,Kyoichi Kaira,Tomonori Nakamura,Koujirou Yamamoto, 2012, Clinical Medicine Insights: Oncology
• Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath, Tohru Aomori,Hironori Makino,Masayuki Sekizuka,Tadahiro Hashita,Takuya Araki,Keiko Iizuka,Tomonori Nakamura,Koujirou Yamamoto, 2012, Drugs in R&D

  DOI
• Effect of genetic polymorphisms (TPMT, ITPA, IMPDH1, XO and MRP4) on the efficacy of low-dose azathioprine therapy in Japanese patients with systemic lupus erythematosus, Ayumu Nagamine,Miki Takenaka,Tohru Aomori,Yuko Okada,Keiju Hiromura,Yoshihisa Nojima,Takuya Araki,Tomonori Nakamura,Koujirou Yamamoto, 2012, American Journal of Health-System Pharmacy
• Ruthenium-catalyzed cycloisomerization of 1,3-dienes, for example, an N-dienyl-2-vinylaniline derivative, leading to a 3-Exomethylene-2-vinylindole derivative and its application to the synthesis of (±)-cinchonaminone, Takao Ogawa,Tomonori Nakamura,Takuya Araki,Koujiro Yamamoto,Satoshi Shuto,Mitsuhiro Arisawa, 2012

  DOI
• Sensitive and simple determination of vitamin K1 in human plasma by ultra-performance liquid chromatography coupled with a fluorescence detector, Izumi Ohno,Takuya Araki,Masashi Kawano,Tomonori Nakamura,Koujirou Yamamoto, 2012

  DOI
• Review of the treatment of non-small-cell lung cancer with gefitinib, Takuya Araki,Hideaki Yashima,Kimihiro Shimizu,Tohru Aomori,Tadahiro Hashita,Kyoichi Kaira,Tomonori Nakamura,Koujirou Yamamoto, 2012
• Effect of ethanol in paclitaxel injections on the ethanol concentration in exhaled breath, Tohru Aomori,Hironori Makino,Masayuki Sekizuka,Tadahiro Hashita,Takuya Araki,Keiko Iizuka,Tomonori Nakamura,Koujirou Yamamoto, 2012

  DOI
• Effect of genetic polymorphisms (TPMT, ITPA, IMPDH1, XO and MRP4) on the efficacy of low-dose azathioprine therapy in Japanese patients with systemic lupus erythematosus, Ayumu Nagamine,Miki Takenaka,Tohru Aomori,Yuko Okada,Keiju Hiromura,Yoshihisa Nojima,Takuya Araki,Tomonori Nakamura,Koujirou Yamamoto, 2012
• Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinoma, Masayuki Sugano,Kimihiro Shimizu,Tetsuhiro Nakano,Seiichi Kakegawa,Yohei Miyamae,Kyoichi Kaira,Takuya Araki,Mitsuhiro Kamiyoshihara,Osamu Kawashima,Izumi Takeyoshi, Nov. 2011, ONCOLOGY REPORTS, 26, 5, 1205, 1211

  DOI
• Correlation between computed tomography findings and epidermal growth factor receptor and KRAS gene mutations in patients with pulmonary adenocarcinoma, Masayuki Sugano,Kimihiro Shimizu,Tetsuhiro Nakano,Seiichi Kakegawa,Yohei Miyamae,Kyoichi Kaira,Takuya Araki,Mitsuhiro Kamiyoshihara,Osamu Kawashima,Izumi Takeyoshi, Nov. 2011, ONCOLOGY REPORTS, 26, 5, 1205, 1211

  DOI
• Clinicopathological Features of Lung Adenocarcinoma With KRAS Mutations, Seiichi Kakegawa,Kimihiro Shimizu,Masayuki Sugano,Yohei Miyamae,Kyoichi Kaira,Takuya Araki,Tetsuhiro Nakano,Mitsuhiro Kamiyoshihara,Osamu Kawashima,Izumi Takeyoshi, Sep. 2011, CANCER, 117, 18, 4257, 4266

  DOI
• Clinicopathological Features of Lung Adenocarcinoma With KRAS Mutations, Seiichi Kakegawa,Kimihiro Shimizu,Masayuki Sugano,Yohei Miyamae,Kyoichi Kaira,Takuya Araki,Tetsuhiro Nakano,Mitsuhiro Kamiyoshihara,Osamu Kawashima,Izumi Takeyoshi, Sep. 2011, CANCER, 117, 18, 4257, 4266

  DOI
• Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma, Yohei Miyamae,Kimihiro Shimizu,Junko Hirato,Takuya Araki,Kazumi Tanaka,Hiroomi Ogawa,Seiichi Kakegawa,Masayuki Sugano,Tetsuhiro Nakano,Yasumasa Mitani,Kyoichi Kaira,Izumi Takeyoshi, Apr. 2011, ONCOLOGY REPORTS, 25, 4, 921, 928

  DOI
• Significance of epidermal growth factor receptor gene mutations in squamous cell lung carcinoma, Yohei Miyamae,Kimihiro Shimizu,Junko Hirato,Takuya Araki,Kazumi Tanaka,Hiroomi Ogawa,Seiichi Kakegawa,Masayuki Sugano,Tetsuhiro Nakano,Yasumasa Mitani,Kyoichi Kaira,Izumi Takeyoshi, Apr. 2011, ONCOLOGY REPORTS, 25, 4, 921, 928

  DOI
• A case of fatal drug intoxication showing a high-density duodenal content by postmortem computed tomography, Rie Sano,Keiko Takahashi,Yoshihiko Kominato,Takuya Araki,Koujiro Yamamoto,Hiroyuki Takei,Hidenori Otake,Sachiko Awata,Hisashi Akuzawa,Yoko Tago,Hideo Aoki, Jan. 2011, LEGAL MEDICINE, 13, 1, 39, 40

  DOI
• A case of fatal drug intoxication showing a high-density duodenal content by postmortem computed tomography, Rie Sano,Keiko Takahashi,Yoshihiko Kominato,Takuya Araki,Koujiro Yamamoto,Hiroyuki Takei,Hidenori Otake,Sachiko Awata,Hisashi Akuzawa,Yoko Tago,Hideo Aoki, Jan. 2011, LEGAL MEDICINE, 13, 1, 39, 40

  DOI
• Clinical screening assay of EGFR mutations by PNA-clamp Smart Amplification Proces Version 2 in lung adenocarcinoma, Araki T,Shimizu K,Nakamura T,Baba M,Kawai Y,Nakamura K,Mitani Y,Obayashi K,Aomori T,Fujita Y,Miyamae Y,Kakegawa S,Kaira K,Lezhava A,Hayashizaki Y,Takeyoshi,Yamamoto K, 2011, Oncology Reports

  DOI
• Clinical screening assay of EGFR mutations by PNA-clamp Smart Amplification Proces Version 2 in lung adenocarcinoma, Araki T,Shimizu K,Nakamura T,Baba M,Kawai Y,Nakamura K,Mitani Y,Obayashi K,Aomori T,Fujita Y,Miyamae Y,Kakegawa S,Kaira K,Lezhava A,Hayashizaki Y,Takeyoshi,Yamamoto K, 2011

  DOI
• 液体調整器具を用いた抗がん薬注射剤調製手技の未熟達者における評価, 藤田行代志,関塚雅之,中村智徳,本徳理恵,阿部正樹,中村克徳,荒木拓也,飯塚惠子,山本康次郎, 2011, 37, 2, 91, 96

  DOI
• Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded Lung Cancer Tissue, Yohei Miyamae,Kimihiro Shimizu,Yasumasa Mitani,Takuya Araki,Yuki Kawai,Masaru Baba,Seiichi Kakegawa,Masayuki Sugano,Kyoichi Kaira,Alexander Lezhava,Yoshihide Hayashizaki,Koujirou Yamamoto,Izumi Takeyoshi, Mar. 2010, JOURNAL OF MOLECULAR DIAGNOSTICS, 12, 2, 257, 264

  DOI
• Mutation Detection of Epidermal Growth Factor Receptor and KRAS Genes Using the Smart Amplification Process Version 2 from Formalin-Fixed, Paraffin-Embedded Lung Cancer Tissue, Yohei Miyamae,Kimihiro Shimizu,Yasumasa Mitani,Takuya Araki,Yuki Kawai,Masaru Baba,Seiichi Kakegawa,Masayuki Sugano,Kyoichi Kaira,Alexander Lezhava,Yoshihide Hayashizaki,Koujirou Yamamoto,Izumi Takeyoshi, Mar. 2010, JOURNAL OF MOLECULAR DIAGNOSTICS, 12, 2, 257, 264

  DOI
• Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon 12 Mutations in Lung Adenocarcinoma Comparison of PNA-Clamp SmartAmp2 and PCR-Related Methods, Takuya Araki,Kimihiro Shimizu,Katsunori Nakamura,Tomonori Nakamura,Yasumasa Mitani,Kyoko Obayashi,Yukiyoshi Fujita,Seiichi Kakegawa,Yohei Miyamae,Kyoichi Kaira,Takefumi Ishidao,Alexander Lezhava,Yoshihide Hayashizaki,Izumi Takeyoshi,Koujirou Yamamoto, Jan. 2010, JOURNAL OF MOLECULAR DIAGNOSTICS, 12, 1, 118, 124

  DOI
• Usefulness of Peptide Nucleic Acid (PNA)-Clamp Smart Amplification Process Version 2 (SmartAmp2) for Clinical Diagnosis of KRAS Codon 12 Mutations in Lung Adenocarcinoma Comparison of PNA-Clamp SmartAmp2 and PCR-Related Methods, Takuya Araki,Kimihiro Shimizu,Katsunori Nakamura,Tomonori Nakamura,Yasumasa Mitani,Kyoko Obayashi,Yukiyoshi Fujita,Seiichi Kakegawa,Yohei Miyamae,Kyoichi Kaira,Takefumi Ishidao,Alexander Lezhava,Yoshihide Hayashizaki,Izumi Takeyoshi,Koujirou Yamamoto, Jan. 2010, JOURNAL OF MOLECULAR DIAGNOSTICS, 12, 1, 118, 124

  DOI
• Influence of CYP2C9 and VKORC1 polymorphisms on time to determine the warfarin maintenance dose., Aomori T,Obayashi K,Fujita Y,Araki T,Nakamura K,Nakamura T,Kurabayashi M,Yamamoto K, 2010, Die Pharmazie
• Influence of CYP2C9 and VKORC1 polymorphisms on time to determine the warfarin maintenance dose., Aomori T,Obayashi K,Fujita Y,Araki T,Nakamura K,Nakamura T,Kurabayashi M,Yamamoto K, 2010
• 臨床応用のためのSNP診断技術, 三谷康正,荒木拓也,太田郁子, 2008, 33, 5, 791, 796
• パニツムマブによる低マグネシウム血症の発症に及ぼす併用薬の影響, 羽鳥 真由;勝見 重昭;八島 秀明;長井 桃子;柴崎 由実;荒木 拓也;山本 康次郎, 36, 306

Books etc

• 臨床検査データブック 2011-2012, 2011
• 臨床検査データブック 2009-2010, 2009
• 臨床検査データブック 2013-2014, 2013
• 医療薬学Ⅰ（スタンダード薬学シリーズⅡ-6）, 2015

Presentations

• Effective application of PNA-clamp in Smart Amplification Process Version 2 for Clinical Diagnosis of KRAScodon 12 mutations in Lung Adenocarcinoma., 13th world conference on lung cancer, 2009
• Determination of genetic polymorphism of CYP2C9 and VKORC1 as a contributor of warfarin dose in Indonesian population, 24th JSSX Annual Meeting, 2009
• Clinical diagnosis of K-ras codon12 mutations in lung adenocarcinomas by new high sensitive method PNA-clamp smart amplification process version 2, 30th American College of Clinical Pharmacy, 2009
• Reduction of vitamin K2 epoxide by VKOR is more potent than vitamin K1 epoxide in human liver microsome, Annual Meeting of the American College of Clinical Pharmacology 2012, 2012
• Correlation Between the Concentration of Darunavir in PBMCs and Plasma in HIV-Infected Patients, Annual Meeting of the American College of Clinical Pharmacy 2012, 2012
• The effect of sex on the pharmacokinetics of tacrolimus in SLE or RA patients with CYP3A5*3/*3, 41th European Society of Clinical PharmacySymposium, 2012
• Assessment of unified inhalation guidance documents for different inhalers and the influence of age on inhalation technique, 18th Congress of the European Association of Hospital Pharmacists, 2013
• RESPONSIVENESS OF VERY LOW-DOSE WARFARIN ASSOCIATED WITH GENETIC VARIANTS OF VKORC1, CYP2C9, CYP4F2, AND CYP2C19 IN INDONESIAN PATIENT, 2012 American society for clinical pharmacology and therapeutics annual meeting, 2012
• INHIBITORY ACTIVITY OF WARFARIN ENANTIOMER ON VITAMIN K1 AND K2 EPOXIDES METABOLISM, 2012 Ameracan society for clinical pharmacology and therapeutics annualmeeting, 2012
• Evaluation of the unified inhalation instructional systems by the cooperation between physicians, hospital and community pharmacists, 18th Congress of the European Association of Hospital Pharmacists, 2013
• Administration of dabigatran with decapsulation, 18th Congressof the European Association of Hospital Pharmacists, 2013
• Comparison of the effect of two intravenous iron, saccharated ferric oxide and cideferron, for iron deficiency anemia, 45th ASHP Midyear Clinical Meeting & Exhibition, 2010
• Pharmacokinetic individualization of high-dose methotrexate therapy for the treatment of osteosarcoma, 45th ASHP Midyear Clinical Meeting & Exhibition, 2010
• The impact of VKORC1 and CYP2C9 genetic polymorphisms on warfarin response in Indonesian patients, 25th JSSX Annual Meeting, 2010
• Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma, The 9th International Conference of the Asian Clinical Oncology Society, 2010
• Effect of genetic polymorphisms on the efficacy of low-dose azathioprine therapy in patients with systemic lupus erythematosus, 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, 2011
• Pharmacodynamics and pharmacokinetics of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in Indonesian patients, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Clinical application for determination of darunavir using very limited volume of plasma by high-performance liquid chromatography with fluorescence detection, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Comparison of the VKOR inhibitory activity by S- and R-warfarin, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Effect of milk thistle (Silybum marianum) on glucose and lipid metabolism, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Effect of atypical antipsychotics on glucose and lipid metabolism, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• The difference of VKOR activity and its inhibition by warfarin between vitamin K1 epoxide and vitamin K2 epoxice., 12th Congress of the European Association of Clinical Phamracology and Therapeutics, 2015
• Determination of plasma concentration of dabigatran by liquid chromatography coupled with time of flight type single mass spectrometry., 14th International Congress of Therapeutic Drug monitoring and Clinical Toxicology, 2015
• Development of a predictive method ofr sensitivity to anti-EGFR Mabs using proteome analysis., 2015 Annual Meeting of the American College of Clinical Pharmacy, 2015
• Pharmacy residency system in Gunma University hospital, The Asian Federation for Pharmaceutical Sciences 2015, 2015
• Significance of three step prescription checking by pharmacists., The Asian Federation for Pharmaceutical Sciences 2015, 2015
• Effect of MDR1 genotype on the intracellular concentration and the clinical efficacy of darunavir in HIV patients, American Society of Clinical Pharmacology and Thrapeutics 2014 Annual Meeting, 2014
• Quantification of an antibody drug, infliximab, in human blood using biomarker analysis technique., International Congress of Therapeutic Drug Monitoring and Clinical Toxicology European Conference, 2014
• Intracellular concentration of Darunavir as an indicator for the clinical efficacy in HIV patients, 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, 2013
• LC-MS/MS method for the quantification of infliximab in human blood, 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, 2013
• Genetic variation of discoidin domain receptor 2, BRAF, EGFR and KRAS in Japanese non-adenocarcinoma lung cancer., Asian Federation of Pharmaceutical Society Meeting 2013., 2013
• The impact of production of DIAZO-IC on the expression of vascular pain caused by dacarbazine injection, Asian Federation of Pharmaceutical Society Meeting, 2013
• Impact of genetic polymorphisms on the conversion ratio from oxycodone to fentanyl, Asian Federation of Pharmaceutical Society Meeting, 2013
• CYP3A4*1G is not associated with the PK-PD of Warfarin in Indonesian patients, Asian Federation of Pharmaceutical Society Meeting, 2013
• Establishment of prediction method for clinical efficacy of antibody drugs using LC-MS/MS with biomarker searching technique, 5th International Conference on Advanced Micro‐Device Engineering, 2013
• Genetic variation of DDR2, BRAF, EGFR and KRAS as therapeutic markers in Japanese non-adenocarcinoma lung cancer, 国際協力型がん薬学研究・指導者コース がん指導薬剤師養成コース（インテンシブ）合同シンポジウム, 2013
• Development of a predictive method for sensitivity to anti-EGFR monoclonal antibodies by analysis of tumor specific proteins in colorectal cancer using mass spectrometry, 国際協力型がん薬学研究・指導者コース がん指導薬剤師養成コース（インテンシブ）合同シンポジウム, 2013
• Retrrospective study assess risk of falls due to administration of hypnotic drugs, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Exploration of predictive marker proteins of anti-EGFR Mabs sensitivity using KRAS wild-tyoe CRC cell lines, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Effects of ethanol in anti-cancer drugs on driving, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Therapeutic drug monitoring of docetaxel: a case report of administration of docetaxel for breast cancer patient receiving rifampicin and clarithromycin treatment for non-tuberculous mycobacteriosis, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Difference of biliary elimination of gadoxetate between geometrical isomers in rat, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Post Graduate Education System of Pharmacist in Gunma Univerrsity Hospital, The 2nd International Seminar on Pharmaceutical Sciences and Technology （ISPST） 2016, 2016
• The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma, The 2nd International Seminar on Pharmaceutical Sciences and Technology （ISPST） 2016, 2016
• The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma, American Society of Clinical Pharmacology and Therapeutics Annual Meeting 2017, 2017
• Therapeutic drug monitoring of docetaxel: a case report of administration of docetaxel for breast cancer patient receiving rifampicin and clarithromycin treatment for non-tuberculous mycobacteriosis, American Society of Clinical Pharmacology and Therapeutics Annual Meeting 2017, 2017
• Effective application of PNA-clamp in Smart Amplification Process Version 2 for Clinical Diagnosis of KRAScodon 12 mutations in Lung Adenocarcinoma., 13th world conference on lung cancer, 2009
• PNA-clamp SmartAmp2を用いたEGFR及びKRAS遺伝子変異高感度検出法の臨床応用, 第３回次世代を担う若手医療薬科学シンポジウム, 2009
• 非小細胞肺癌におけるMDM2遺伝子多型と喫煙、EGFR・KRAS遺伝子変異との関連についての検討, 第109回日本外科学会定期学術集会, 2009
• SMAP法を用いた臨床検体からのがん関連遺伝子変異検出(EGFR、K-ras), 第19回生物試料分析科学会大会, 2009
• 個別化医療のためのSMAP法を用いたEGFR, K-ras遺伝子変異検出, 第18回日本医療薬学会年会, 2008
• 肺腺癌におけるKRAS変異と喫煙歴、病理所見の検討, 第50回日本肺癌学会総会, 2009
• Determination of genetic polymorphism of CYP2C9 and VKORC1 as a contributor of warfarin dose in Indonesian population, 24th JSSX Annual Meeting, 2009
• Clinical diagnosis of K-ras codon12 mutations in lung adenocarcinomas by new high sensitive method PNA-clamp smart amplification process version 2, 30th American College of Clinical Pharmacy, 2009
• 静注用鉄剤である含糖酸化鉄およびシデフェロンのヘモグロビン値上昇の比較, 医療薬学フォーラム2010／第18回クリニカルファーマシーシンポジウム, 2010
• ワルファリン維持投与量に対するCYP4F2遺伝子多型の影響の検討, 日本薬学会第130年会, 2010
• 肺腺癌におけるKras変異と喫煙歴、病理所見、遺伝子変異形式の検討, 第27回日本呼吸器外科学会総会, 2009
• SMAP法による肺癌の遺伝子解析 様々な臨床検体を用いた検討, 第109回日本外科学会定期学術集会, 2009
• Reduction of vitamin K2 epoxide by VKOR is more potent than vitamin K1 epoxide in human liver microsome, Annual Meeting of the American College of Clinical Pharmacology 2012, 2012
• Correlation Between the Concentration of Darunavir in PBMCs and Plasma in HIV-Infected Patients, Annual Meeting of the American College of Clinical Pharmacy 2012, 2012
• The effect of sex on the pharmacokinetics of tacrolimus in SLE or RA patients with CYP3A5*3/*3, 41th European Society of Clinical PharmacySymposium, 2012
• 医療薬学研究の成果を論文に投稿しよう！私はこのようにして論文を書いている, 第22回日本医療薬学会年会, 2012
• PNA-clamp SmartAmp2 を用いたEGFRおよびKRAS遺伝子解析法の構築と臨床応用, 第22回日本医療薬学会年会, 2012
• マリアアザミ (Silybum marianum) の耐糖能および脂質代謝異常改善作用物質の探索, 日本薬学会第132年会, 2012
• 骨肉腫患者に対するメトトレキサート大量療法の高濃度維持を目的とした投与設計, 第61回東日本整形災害外科学会, 2012
• ダルナビルのPBMC及び血漿中濃度に影響を与える因子の検討, 第56回日本薬学会関東支部大会, 2012
• Vitamin K1およびvitamin K2の代謝に対するVKOR活性の比較検討, 第56回日本薬学会関東支部大会, 2012
• Assessment of unified inhalation guidance documents for different inhalers and the influence of age on inhalation technique, 18th Congress of the European Association of Hospital Pharmacists, 2013
• 診療予約データを利用した外来院内処方箋発行予約システムの構築, 第22回日本医療薬学会年会, 2012
• Effect of factor on concentration of darunavir in human plasma and PBMC in HIV patient, 第6回次世代を担う若手医療薬科学シンポジウム, 2012
• INHIBITORY ACTIVITY OF WARFARIN ENANTIOMER ON VITAMIN K1 AND K2 EPOXIDES METABOLISM, 2012 Ameracan society for clinical pharmacology and therapeutics annualmeeting, 2012
• RESPONSIVENESS OF VERY LOW-DOSE WARFARIN ASSOCIATED WITH GENETIC VARIANTS OF VKORC1, CYP2C9, CYP4F2, AND CYP2C19 IN INDONESIAN PATIENT, 2012 American society for clinical pharmacology and therapeutics annual meeting, 2012
• Evaluation of the unified inhalation instructional systems by the cooperation between physicians, hospital and community pharmacists, 18th Congress of the European Association of Hospital Pharmacists, 2013
• Administration of dabigatran with decapsulation, 18th Congressof the European Association of Hospital Pharmacists, 2013
• Comparison of the effect of two intravenous iron, saccharated ferric oxide and cideferron, for iron deficiency anemia, 45th ASHP Midyear Clinical Meeting & Exhibition, 2010
• Pharmacokinetic individualization of high-dose methotrexate therapy for the treatment of osteosarcoma, 45th ASHP Midyear Clinical Meeting & Exhibition, 2010
• 食道癌化学放射線療法における免疫栄養剤併用の有用性, 第66回日本食道学会学術集会, 2012
• SMAP法を用いたEGFR及びK-ras遺伝子変異の迅速診断の評価, 日本薬学会第128年会, 2008
• リンパ節転移をきたした肺腺癌手術症例におけるEGFR遺伝子変異と臨床病理学的因子との関連, 第109回日本外科学会定期学術集会, 2009
• 高速液体クロマトグラフィーを用いた高感度ダルナビル血中濃度測定法の開発, 第25回日本エイズ学会学術集会, 2011
• 外来化学療法センターにおけるリウマチ患者に対する薬剤師の関わり, 第61回東日本整形災害外科学会, 2012
• Difference of vitamin K1and K2 in the VKOR activity and its inhibition by warfarin enantiomers, 第6回次世代を担う若手医療薬科学シンポジウム, 2012
• The impact of VKORC1 and CYP2C9 genetic polymorphisms on warfarin response in Indonesian patients, 25th JSSX Annual Meeting, 2010
• CYP2C19活性低下およびCYP3A5欠損患者においてイトラコナゾールからボリコナゾールへの変更によりタクロリムス血中濃度が5倍上昇した症例, 第20回日本医療薬学会年会, 2010
• 透析液中のセファゾリンの安定性についての検討, 第20回日本医療薬学会年会, 2010
• The Contribution of CYP3A5 and MDR1 (ABCB1) Polymorphisms on the pharmacokinetics of tacrolimus in patients with Rheumatoid arthritis and Lupus nephritis, 第４回次世代を担う若手医療薬科学シンポジウム, 2010
• Contribution of genetic polymorphisms to the efficacy of low-dose azathioprine therapy in Japanese patients with systemic lupus erythematosus, 第４回次世代を担う若手医療薬科学シンポジウム, 2010
• 貧血患者におけるヘモグロビン値に対する2 種の静注用鉄剤の効果比較, 日本薬学会第131 年会, 2011
• SmartAmp法を用いた抗 EGFR抗体薬投与前KRAS遺伝子検査, 第58回日本臨床検査医学会学術集会, 2011
• 肝ミクロソームを用いたSおよびRワルファリンによるVKOR阻害活性の比較検討, 第55回日本薬学会関東支部大会, 2011
• 第二世代抗精神病薬の糖代謝・脂質代謝異常への影響, 第55回日本薬学会関東支部大会, 2011
• Monitoring of blood levels of raltegravir in HIV-infected patients receiving hemodialysis, 日本薬物動態学会第26回年会, 2011
• Association of genotype, pharmacokinetics of vitamin Ks, and response of warfarin, 第5回次世代を担う若手医療薬科学シンポジウム, 2011
• Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma, The 9th International Conference of the Asian Clinical Oncology Society, 2010
• Effect of genetic polymorphisms on the efficacy of low-dose azathioprine therapy in patients with systemic lupus erythematosus, 10th Congress of the European Association for Clinical Pharmacology and Therapeutics, 2011
• Pharmacodynamics and pharmacokinetics of warfarin associated with genetic polymorphisms of VKORC1 and CYP2C9 in Indonesian patients, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Clinical application for determination of darunavir using very limited volume of plasma by high-performance liquid chromatography with fluorescence detection, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Comparison of the VKOR inhibitory activity by S- and R-warfarin, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Effect of milk thistle (Silybum marianum) on glucose and lipid metabolism, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• Effect of atypical antipsychotics on glucose and lipid metabolism, 2nd Asian Federation for Pharmaceutical Sciences 2011, 2011
• 果実成分による CYP3A4 の MBI 特性に対する遺伝子変異の影響, 日本薬学会第133年会, 2013
• 免疫栄養療法併用によるがん化学放射線療法完遂率の向上効果の検討, 第46回制癌剤適応研究会, 2013
• メトトレキサート大量療法施行時の高濃度維持を目的とした投与設計法の確立, 第46回制癌剤適応研究会, 2013
• ダビガトランを脱カプセルして経管投与した症例の血中濃度解析, 第77回日本循環器学会学術集会, 2013
• 免疫栄養療法が癌化学放射線療法の完遂率に与える影響, 第28回日本静脈経腸栄養学会, 2013
• エリブリンメシル酸塩およびパクリタキセル投与患者における好中球減少症および末梢神経障害発現率の比較, 第46回制癌剤適応研究会, 2013
• 新規遺伝子増幅技術SmartAmp法を用いた肺癌におけるKRAS遺伝子変異の解析, 第110回日本外科学会定期学術集会, 2010
• 透析を要するHIV感染者におけるraltegravirの血中濃度モニタリング(TDM)の試み, 第25回日本エイズ学会学術集会, 2011
• 散剤調剤時の最適な賦形量の検討, 第34回 群馬県病院薬剤師会学術大会, 2016
• ボリコナゾール点眼液の安定性評価, 第34回 群馬県病院薬剤師会学術大会, 2016
• 群馬大学医学部附属病院薬剤部における薬剤師レジデント制度について, 第34回 群馬県病院薬剤師会学術大会, 2016
• 悪性リンパ腫に対するSMILE療法中に起きた代謝性アシドーシスの原因解明への取り組み, 第5回 日本薬剤師レジデントフォーラム, 2016
• 群馬大学医学部附属病院における薬剤師レジデントを通して得たもの, 第5回 日本薬剤師レジデントフォーラム, 2016
• The difference of VKOR activity and its inhibition by warfarin between vitamin K1 epoxide and vitamin K2 epoxice., 12th Congress of the European Association of Clinical Phamracology and Therapeutics, 2015
• Determination of plasma concentration of dabigatran by liquid chromatography coupled with time of flight type single mass spectrometry., 14th International Congress of Therapeutic Drug monitoring and Clinical Toxicology, 2015
• Development of a predictive method ofr sensitivity to anti-EGFR Mabs using proteome analysis., 2015 Annual Meeting of the American College of Clinical Pharmacy, 2015
• Pharmacy residency system in Gunma University hospital, The Asian Federation for Pharmaceutical Sciences 2015, 2015
• Significance of three step prescription checking by pharmacists., The Asian Federation for Pharmaceutical Sciences 2015, 2015
• スルファメトキサゾール・トリメトプリムにより低血糖症状を来したプレドニゾロン投与中の腸管ベーチェット病患者の一例, 第４回日本薬剤師レジデントフォーラム, 2015
• RF-IDを利用した治験内服処方薬の調剤進捗管理システムの導入と評価, 群馬県病院薬剤師会 第33回学術大会, 2015
• スニチニブの幾何異性体による細胞増殖抑制効果の比較, 第５９回日本薬学会関東支部大会, 2015
• アプレピタントによる補助療法ががん化学療法の治療経過に与える影響, 第５９回日本薬学会関東支部大会, 2015
• Effect of MDR1 genotype on the intracellular concentration and the clinical efficacy of darunavir in HIV patients, American Society of Clinical Pharmacology and Thrapeutics 2014 Annual Meeting, 2014
• Quantification of an antibody drug, infliximab, in human blood using biomarker analysis technique., International Congress of Therapeutic Drug Monitoring and Clinical Toxicology European Conference, 2014
• Development approach using LC-MS/MS and biomarker analytical technique for the quantification of infliximab in human blood., 医療薬学フォーラム2014／第22回クリニカルファーマシーシンポジウム, 2014
• Development of a rapid evaluation method for therapeutic efficacy of antibiotics usin quantification of bacterial ribosomal RNA precursors., 第８回次世代を担う若手医療薬科学シンポジウム, 2014
• RF-ID を利用した調剤進捗管理システムの導入と評価, 平成25年度大学病院情報マネジメント部門連絡会議, 2014
• 遺伝子多型解析に基づくオピオイド鎮痛薬の換算比の検討, 日本薬学会第134年会, 2014
• 各種CYP3A4変異型分子に対するグレープフルーツ果汁抽出物およびその成分のMBI特性, 日本薬学会第134年会, 2014
• CYP3A4変異型分子におけるtestosterone及びmidazolamの代謝に対する競合阻害剤の阻害強度の比較, 日本薬学会第134年会, 2014
• 仙骨骨肉腫による体性痛および神経障害性疼痛にオキシコドンが有効であった1例, 第29回 群馬緩和医療研究会, 2014
• ビーフリード持続投与によるBacillus cereus血流感染リスクの評価, 医療薬学フォーラム２０１４／第２２回クリニカルファーマシーシンポジウム, 2014
• Intracellular concentration of Darunavir as an indicator for the clinical efficacy in HIV patients, 11th Conference of the European Association for Clinical Pharmacology and Therapeutics, 2013
• Genetic variation of discoidin domain receptor 2, BRAF, EGFR and KRAS in Japanese non-adenocarcinoma lung cancer., Asian Federation of Pharmaceutical Society Meeting 2013., 2013
• CYP3A4*1G is not associated with the PK-PD of Warfarin in Indonesian patients, Asian Federation of Pharmaceutical Society Meeting, 2013
• LC-MS/MS method for the quantification of infliximab in human blood, 13th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology, 2013
• The impact of production of DIAZO-IC on the expression of vascular pain caused by dacarbazine injection, Asian Federation of Pharmaceutical Society Meeting, 2013
• Impact of genetic polymorphisms on the conversion ratio from oxycodone to fentanyl, Asian Federation of Pharmaceutical Society Meeting, 2013
• Establishment of prediction method for clinical efficacy of antibody drugs using LC-MS/MS with biomarker searching technique, 5th International Conference on Advanced Micro‐Device Engineering, 2013
• 動態パラメータ解析に基づくメトトレキサート大量療法における投与設計法の検討, 第46回制癌剤適応研究会, 2013
• 小児急性リンパ性白血病患者に対するメトトレキサート大量療法時の血中メトトレキサート濃度と投与回数の関係, 第40回日本小児臨床薬理学会学術集会, 2013
• 吸入連携システムの構築と問題点, 第23回日本呼吸ケア・リハビリテーション学会学術集会, 2013
• がん化学療法に対する免疫栄養療法の併用効果, 医療薬学フォーラム2013/第21回クリニカルファーマシーシンポジウム, 2013
• 吸入療法における標準手順書の作成とその有用性, 医療薬学フォーラム2013/第21回クリニカルファーマシーシンポジウム, 2013
• Vitamin K1及びVitamin K2に対するVKOR活性の違い, 第57回日本薬学会関東支部大会, 2013
• ダカルバジン分解物DIAZO-IC生成量に影響を与える要因の検討, 第57回日本薬学会関東支部大会, 2013
• ダビガトラン血中濃度とaPTT値の相関性における採血時間の影響, 第57回日本薬学会関東支部大会, 2013
• Genetic variation of DDR2, BRAF, EGFR and KRAS as therapeutic markers in Japanese non-adenocarcinoma lung cancer, 国際協力型がん薬学研究・指導者コース がん指導薬剤師養成コース（インテンシブ）合同シンポジウム, 2013
• The factors acting for the clinicaol efficacy of darunavir and the intracellular concentration of darunavir in HIV patients., 第7回次世代を担う若手医療薬科学シンポジウム, 2013
• Development approach using LC-MS/MS and biomarker analytical technique for the quantification of infliximab in human blood., 第7回次世代を担う若手医療薬科学シンポジウム, 2013
• Effects of the MDR1 gene variant C3455T on the plasma conc3entration of dabigatran in Japanese patients., 第78回日本循環器学会学術集会, 2014
• 群馬大学医学部附属病院における薬剤師レジデント研修プログラム, 第４回日本薬剤師レジデントフォーラム, 2015
• 薬剤師レジデントの研修期間と注射薬調剤過誤件数の関係, 第４回日本薬剤師レジデントフォーラム, 2015
• 散剤の賦形方法についての検討, 群馬県病院薬剤師会第33回学術大会, 2015
• CYP3A4 遺伝的valiantに対する競合阻害剤の阻害特性の体系的比較, 第５９回日本薬学会関東支部大会, 2015
• がん化学療法に伴う副作用対策としての免疫栄養療法の臨床的有用性, 第32回 群馬県病院薬剤師会実務研究会, 2014
• Darunavir(DRV)増量を含むレジメン変更が髄液・血中HIV-RNA量の低下と認知機能改善に寄与した一例, 第27回日本エイズ学会学術集会・総会, 2013
• Development of a predictive method for sensitivity to anti-EGFR monoclonal antibodies by analysis of tumor specific proteins in colorectal cancer using mass spectrometry, 国際協力型がん薬学研究・指導者コース がん指導薬剤師養成コース（インテンシブ）合同シンポジウム, 2013
• CYP3A4各変異型分子種の代謝活性に対するMBI阻害剤の阻害強度の体系的比較, 日本薬学会第136年会, 2016
• Retrrospective study assess risk of falls due to administration of hypnotic drugs, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• 免疫栄養療法ががん化学療法に与える影響の評価－プロスペクティブスタディ－, 医療薬学フォーラム2016／第24回クリニカルファーマシーシンポジウム, 2016
• Exploration of predictive marker proteins of anti-EGFR Mabs sensitivity using KRAS wild-tyoe CRC cell lines, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Effects of ethanol in anti-cancer drugs on driving, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Therapeutic drug monitoring of docetaxel: a case report of administration of docetaxel for breast cancer patient receiving rifampicin and clarithromycin treatment for non-tuberculous mycobacteriosis, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Difference of biliary elimination of gadoxetate between geometrical isomers in rat, 10th Young Investigators Symposium on Clinical Pharmaceutical Sciences, 2016
• Post Graduate Education System of Pharmacist in Gunma Univerrsity Hospital, The 2nd International Seminar on Pharmaceutical Sciences and Technology （ISPST） 2016, 2016
• The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma, The 2nd International Seminar on Pharmaceutical Sciences and Technology （ISPST） 2016, 2016
• The influence of the genetic polymorphisms of efflux transporter on DRV levels in PBMC and plasma, American Society of Clinical Pharmacology and Therapeutics Annual Meeting 2017, 2017
• Therapeutic drug monitoring of docetaxel: a case report of administration of docetaxel for breast cancer patient receiving rifampicin and clarithromycin treatment for non-tuberculous mycobacteriosis, American Society of Clinical Pharmacology and Therapeutics Annual Meeting 2017, 2017
• CYP3A4 genetic variants に対する各種アゾール系抗真菌薬の阻害特性の比較, 日本薬学会第137年会, 2017
• 食道癌サルベージ手術症例における手術前の筋肉量と合併症発現リスクおよび長期予後の関係に関する調査, 第32回日本静脈経腸栄養学会学術集会, 2017

Research Projects

• Competitive research funding
• Individualized pharmacotherapy, Grant-in-Aid for Scientific Research, Competitive research funding